Skip to main content
PLOS One logoLink to PLOS One
. 2021 May 20;16(5):e0251978. doi: 10.1371/journal.pone.0251978

Acceptability of a nurse-led, person-centred, anticipatory care planning intervention for older people at risk of functional decline: A qualitative study

Dagmar A S Corry 1,2,*, Julie Doherty 1,2, Gillian Carter 1,2, Frank Doyle 3, Tom Fahey 3, Peter O’Halloran 1,2, Kieran McGlade 4, Emma Wallace 3,5, Kevin Brazil 1,2,*
Editor: Catherine J Evans6
PMCID: PMC8136649  PMID: 34015046

Abstract

Background

As the population of older adults increases, the complexity of care required to support those who choose to remain in the community amplifies. Anticipatory Care Planning (ACP), through earlier identification of healthcare needs, is evidenced to improve quality of life, decrease aggressive interventions, and prolong life. With patient acceptability of growing importance in the design, implementation, and evaluation of healthcare interventions, this study reports on the acceptability of a primary care based ACP intervention on the island of Ireland.

Methods

As part of the evaluation of a feasibility cluster randomized controlled trial (cRCT) testing an ACP intervention for older people at risk of functional decline, intervention participants [n = 34] were interviewed in their homes at 10-week follow-up to determine acceptability. The intervention consisted of home visits by specifically trained registered nurses who assessed participants’ health, discussed their health goals and plans, and devised an anticipatory care plan in collaboration with participants’ GPs and adjunct clinical pharmacist. Thematic analysis was employed to analyze interview data. The feasibility cRCT involved eight general practitioner (GP) practices as cluster sites, stratified by jurisdiction, four in Northern Ireland (NI) (two intervention, two control), and four in the Republic of Ireland (ROI) (two intervention, two control). Participants were assessed for risk of functional decline. A total of 34 patients received the intervention and 31 received usual care.

Findings

Thematic analysis resulted in five main themes: timing of intervention, understanding of ACP, personality & individual differences, loneliness & social isolation, and views on healthcare provision. These map across the Four Factor Model of Acceptability (‘4FMA’), a newly developed conceptual framework comprising four components: intervention factors, personal factors, social support factors, and healthcare provision factors.

Conclusion

Acceptability of this primary care based ACP intervention was high, with nurses’ home visits, GP anchorage, multidisciplinary working, personalized approach, and active listening regarded as beneficial. Appropriate timing, and patient health education emerged as vital.

1. Introduction

High quality, personalized health care provision for older people at risk of functional decline remains the objective of health care systems in Northern Ireland (NI) and the Republic of Ireland (ROI) [13]. The United Kingdom National Health Service (NHS) and the Health Service Executive (HSE) in ROI strive to improve the quality of life for older people, enable them to retain their independence, and to live in their own homes for as long as possible. With an ever-increasing median age older people often live with multi-morbidities, making their long-term care more complex [46]. Staff shortages and wider systemic problems [7,8] result in reactive healthcare systems and the needs of older people often remain unmet [914], with inequalities of access to services.

Health systems in both jurisdictions strive to move from a medical care model towards a person-centred, holistic primary care model [15] with demonstrated benefits to patients’ health [16]. It is widely acknowledged that preventative care models within primary care settings can reduce hospital and care home admissions and improve quality of life [17,18].

Person-centred care has been shown to improve patient experience, care quality, and health outcomes, including for those with long-term conditions [1619], and to be more cost-effective [20]. Patients are less likely to use emergency hospital services, and more likely to adhere to their treatment and medication regimes when playing a collaborative role in their health and care [16]. Personalized, sensitive, and timely management of long-term conditions is key to facilitating this modern model of care. Anticipatory care planning (‘ACP’) has been defined as a process supporting those living with long term conditions to plan for an expected change in health or social status, incorporating health improvement and staying well [21]. ACP has a fundamental role to play in a person-centred, forward looking health care system in order to meet each patient’s needs, respect their wishes and values, relieve their symptoms, and prevent or delay deterioration wherever possible. In ACP the patient is an active participant in their care planning rather than a mere recipient of care [16], and patients’ perceptions as to whether such an intervention is acceptable to them will determine its success. Acceptability reflects the extent to which patients receiving a healthcare intervention consider it to be appropriate [22]. In the UK, the Medical Research Council [23] has significantly increased its references to acceptability in their guidance documents for evaluating complex interventions [2426], indicative of the growing importance of this construct. Sekhon, et al. [22: p.5] defined acceptability as:

‘… a multi-faceted construct that reflects the extent to which people delivering or receiving a healthcare intervention consider it to be appropriate, based on anticipated or experienced cognitive and emotional responses to the intervention.’

Against this background, the current paper aims to explore patient acceptability of a nurse-led, person-centred primary care ACP intervention for older adults at risk of functional decline on the island of Ireland.

2. Method

2.1 Design and procedure

This paper reports on patient acceptability of the intervention, and follows the COREQ guidelines for reporting qualitative research [27] (see S1 File) and the TIDieR Checklist [28] (see S2 File).

2.1.1 The intervention

The ACP intervention protocol has been described in detail elsewhere [29]. A feasibility cluster randomized controlled trial was conducted where, depending on the complexity of needs, those in the intervention group received up to three home visits (one to two hours in duration) over 10 weeks by specially trained registered nurses who assessed their physical, mental, and social health and discussed with them their health concerns, goals, and plans. Preceding the home visits, and to ensure consistency and a personalized care approach, registered nurses (n = 5) from both jurisdictions completed a three-day training programme designed to orientate them to the intervention and study procedures. The training was facilitated by a clinician expert in the field, and the programme included study overview, principles and practice of personalized care, shared decision making, conduction of a standardized, person-centred, holistic assessment with the EASY-Care [30] tool, and completing a medication review in collaboration with a clinical pharmacist. The ACP assessment using EASY-Care was conducted with the aid of a medical summary provided by the GP practice, including details of the patients’ health conditions and prescribed medications. In consultation with participants’ GPs and an adjunct clinical pharmacist who conducted the medication review the nurses developed a personalized care plan supported by the GP, and this was then shared with the patient.

The RE-AIM conceptual framework guided the evaluation of the ACP intervention [19,31]. Under the ‘Adoption’ component within this framework thematic analysis [32] was employed to explore the acceptability of the nurse-led ACP intervention for older adults at risk of functional decline. This involved qualitative interviews with participants in their own homes at 10-week follow-up (August to October 2019) following completion of the intervention. During the visit, quantitative data was also collected. Participants completed quantitative questionnaires for the 10-week follow-up, then the qualitative interview. Family carers could take part in the interviews at the participant’s discretion. The qualitative interviews had a median average length of nine minutes (range: three to 24 minutes), were audio recorded and transcribed verbatim, and were accompanied by field notes. The interviews were conducted by an experienced female researcher (DC) who had not met the participants prior to interview.

2.2 Sample

Eight general practitioner (GP) practices were assigned as cluster sites to either the intervention or control arm (four per group). Practices were stratified by jurisdiction, and further by rurality prior to randomisation. GP database systems were searched to identify eligible participants and a chart audit and PRISMA-7 screening form [25] used to screen for risk of functional decline for inclusion. The inclusion criteria were aged 70+; two or more chronic medical conditions; four or more regularly prescribed medications; a PRISMA-7 score of ≥ 3; a hospital admission in the previous year; three or more physician visits in the past year, and the ability to complete an English language questionnaire. Full details can be found in the protocol paper [29]. PRISMA-7 is considered a best-practice tool to identify patients at risk of frailty in general practice, with those obtaining a score of ≥3 recognized as being at increased risk [33,34].

Out of 73 patients meeting eligibility, 65 were recruited and randomly allocated to intervention (n = 34) or control (n = 29) group after consent and baseline data collection. All patients in the intervention group were invited to complete a qualitative interview at 10-week follow-up (August to October, 2019) to explore the acceptability of the ACP intervention.

2.3 Interview schedule

A semi-structured interview schedule guide was developed consisting of questions pertaining to patient acceptability (appropriateness, benefits, and convenience) of the intervention. The schedule was informed by the RE-AIM framework [31,35], and questions were based on a review of related research and the expertise of the research team, including patient and public involvement (PPI). Following GRIPP guidelines on PPI reporting [36] we engaged three PPI (one in ROI, two in NI) in an advisory capacity to attend regular project team meetings and to discuss progression, next steps, and consult on study documents, including qualitative and quantitative interview schedules, to ensure the vital lay person perspective is incorporated. An example of PPI input to the qualitative interview schedule is the change from ‘Did you feel actively involved in your discussions with the nurse to identify your healthcare needs?’ to ‘Did you have enough input in identifying your health needs and developing your care plan?’ Interview questions assessed patient perceptions of the intervention including the overall intervention, its component parts (patient meetings, assessment, patient education on anticipatory care planning), implementation (was the home environment suitable for meetings, were the contents reviewed in meetings helpful) and suggestions for improvements to the intervention. The interview schedule guided discussions and when necessary, prompts were used. All interviews took part between August and October 2019. Topic guide items included the following:

  • ‘What did you expect from the care planning exercise before meeting with the nurse for the first time?’

  • ‘How was the overall process of taking part in the care planning exercise?’

  • ‘Did you have enough input in identifying your health needs and developing your care plan?’

  • ‘What is the value of completing an anticipatory care plan?’

  • ‘Did your taking part in the study help your life in any way?’

2.4 Ethical considerations

Ethical approval was obtained in the ROI from the Research Ethics Committee, Irish College of General Practitioners in January 2019 (reference ICGP2018.4.10). In NI approval was received from the Office for Research Ethics, Northern Ireland (reference 19/NI/0001). Following ethical approval and prior to individual baseline data collection visits between February and June 2019, all participants provided written, informed consent to participate in, and be interviewed about, the study.

2.5 Data analysis

NVivo-12 was used to help organize and manage the data. The lead author thematically analyzed the transcribed interview data [28] in an inductive approach, in collaboration with another member of the research and writing team (KB). The intervention nurses were not part of the writing team. We created an open and modifiable codebook, sought, identified, and interpreted patterns, commonalities and differences, leading to a theme structure and final thematic framework. We used data triangulation (interviews, notes, and observation), source triangulation (participants from two jurisdictions) as well as researcher triangulation (two researchers involved in data analysis) in order to strengthen our findings and improve rigour. Researchers observed reflexivity to minimise potential bias and influence. Pseudonyms (IDs) were used; IDs ending in NI denote participants from NI; those ending in ROI denote participants from the ROI. IDs beginning with L and F indicate urbanicity, while those beginning with M and E show rurality.

3. Findings

There was no attrition (n = 34; ROI = 19 (55.9%); NI = 15 (44.1%), with all of the intervention participants agreeing to be interviewed. Table 1 below provides a brief summary of intervention participant characteristics; Table 2 in (S3 File) offers a detailed overview.

Table 1. Intervention participant characteristics summary.

Characteristics Details/Inclusion Criterion (IC) Mean (SD) Number (%)
Gender distribution Female - n = 16 (47.06%)
Male n = 18 (52.94%)
Age: 70+ years IC M = 80.13 (5.70) n = 34 (100%)
Prisma-7 score ≥3 IC M = 4.15 (1.12) n = 34 (100%)
Marital status & living arrangements Married - n = 21 (61.8%)
Living with partner n = 13 (38.2%)
Living with adult children n = 8 (23.5%)
Living alone n = 13 (38.2%)
• Widowed n = 8 (23.5%)
• Divorced n = 3 (8.8%)
• Single n = 2 (5.9%)
Rural/Urban Distribution Rural - n = 14 (41.18%)
Urban n = 20 (58.82%)
Medications IC M = 11.03 (3.59) n = 34 (100%)
Number of hospital inpatient nights in previous year IC M = 6.4 (26.5) n = 34 (100%)
Physician visits in previous year IC M = 5.2 (3.4) n = 34 (100%)
Ability to complete an English language questionnaire IC - N = 34 (100%)
Family carer participation female (spousal) carer - n = 1 (2.94%)

The average PRISMA-7 score of 4.15 (1.12) in our sample was indicative of an increased risk of frailty and the need for further clinical review. As per inclusion criteria all participants had two or more chronic conditions; were taking on average 11.39 medications; had 5.2 GP visits during the past year; and an average of 6.4 inpatient nights in the previous year. Only one family carer actively took part in the interview.

All participants were white European. Gender was evenly distributed, with a mean sample age of 80.13. The majority were married (61.8%) and lived in urban areas (58.82%).

Analysis of interview data resulted in five main themes: Timing of intervention, understanding of ACP, personality & individual differences, social isolation, and views on healthcare provision. Based on these themes we developed an overarching conceptual framework of patient acceptability onto which these five main themes mapped. The new framework comprises four interacting components: intervention factors, personal factors, social support factors, and healthcare provision factors, and forms the basis of the Four Factor Model of Acceptability (‘4FMA’). The 4FMA assists the evaluation of patient acceptability by recognising its multifactorial nature, and identifying facilitators and barriers. The four components of the model, along with their respective main themes are illustrated in Fig 1 below. Details of our findings in each of those components and their main themes are presented in the following.

Fig 1. Four factor model of patient acceptability of nurse-led anticipatory care planning intervention (‘4FMA’).

Fig 1

3.1 Intervention factors

The overarching component of ‘intervention factors’ on the 4FMA includes aspects of the intervention which facilitated or hindered acceptability. Appropriate timing was key to ensure acceptability. Lack of understanding of ACP was a barrier, indicating that improving health literacy should be a priority. The home visits, the psychosocial aspect of the nurses’ visits, and their ability to actively listen and build rapport were facilitators, as were the practical support they provided and the pharmacist’s medication review.

3.1.1 Timing of intervention

Many participants did not want to contemplate a less able future and felt they were ‘not there yet’. They believed that the questions posed to them as part of the intervention were perhaps not all relevant as they felt physically and mentally quite well although some discussed their fear of deteriorating health and how the intervention helped them face this.

‘It’s made me think about a lot of things that I wasn’t trying to think about, and didn’t want to think about, and it’s like facing your fears. If you face your fears, you are not afraid of them then.’

(L011NI).

While some did not regard the intervention as appropriate for them at this point in time, ‘It’s hard to judge what we have in front of us. I couldn’t possibly judge that.’ (M004NI), others were able to identify immediate benefits.

‘I got the opportunity to say I may need help with stairs or what not in a few years’ time. Otherwise, I wouldn’t have had that opportunity to say that, and I am sure I am not the only one that would be in that position.’

(L010NI).

3.1.2 Understanding of ACP

The intervention was viewed favourably by participants, as attested by the affirming feedback during interviews, illustrated by the quotes throughout the findings. However, some considered themselves to be in relatively good health and, therefore, believed it was perhaps not immediately beneficial to them.

‘Tomorrow, next week, six months’ time, it might be far more relevant for me, and at the present minute I would have said it wasn’t terribly relevant.’

(M004NI).

In contrast, others found the intervention appropriate and beneficial, valuing the information provided and knowledge gained.

‘I think it helped because it gives you an idea of what can happen in the future and what help you can get you know. The nurses explained a whole lot of that too by saying about, as you get older you might need a care package or you might need help, so I think it was very informative and it was helpful.’

(L005NI).

3.1.3 Views on home visits

The home visits were well received by all participants, with high praise for the nurses, and several participants expressing hope to receive regular such nurses’ visits over a longer period to ensure continued monitoring and support.

‘What I would like for somebody to, say, every so often just keep a check on me.’

[F91087ROI].

Participants benefitted from the information, and the practical and emotional support provided, acknowledging the appropriateness of the intervention.

‘They recognized things that I was going through, the loss of my friend, they made great suggestions about what I could do.’

(L011NI).

3.1.4 Trust and rapport building

The nurses’ proficient, person-centred attitude was of great importance for patient acceptability of the intervention as a whole, and the home visits in particular.

‘They [nurses] were both professional, and well-meaning, and intelligent people so I felt quite at ease with them.’

(M008NI).

Indicative of the nurses’ ability to build rapport and trust, participants reported they made them feel comfortable and relaxed, and they appreciated the effort to come and see them in their homes as it was more convenient for them.

‘You feel more at home in your own surroundings, maybe you are more likely to tell them things that you might not discuss in more formal surroundings.’

(M008NI).

Indeed, for some it would have been challenging to meet elsewhere due to mobility problems.

3.1.5 Listening and emotional support

The appropriateness of active and compassionate listening became very clear, and many participants said that the most beneficial aspect of the intervention for them was the caring and personal contact. They felt reassured and less ‘forgotten about’ (M006NI). Home visits averaged 90 minutes’ duration which allowed for a relaxed approach and time to build rapport and offer personalized support. ‘They spent time with me. I didn’t feel rushed.’ (L011NI). Participants felt safe to talk about emotional difficulties as well as physical conditions, appreciating the benefits and convenience of a whole-person approach.

‘I found it very informative, they were friendly, and I felt as if somebody actually cared and it was very reassuring. And I think they helped me a lot because I talked to them and I felt free to talk to them. And in fact they cared. Sometimes when you get older you feel people don’t care about you anymore and you are useless, and you know, you are just a bother. But it was the opposite of that.’

(L011NI).

3.1.6 Practical support

Participants reported having derived a range of practical benefits from the nurses’ visits, including dietary changes (E32854ROI), exercise advice (E54137ROI), guidance with personal arrangements, e.g., making a will (E69601ROI), a Do-Not-Resuscitate order (E69601ROI, F91087ROI), assistance with tax-free home adaptations (L005NI), and social prescribing (F44050ROI).

‘First of all: I made a will, I didn’t do that before the nurse came.’

(E69601ROI).

3.1.7 Medication review

The convenience of the medication review was recognised; indeed, some participants regarded the review as the most impactful element of the intervention.

‘And one thing that struck me actually which I think was positive, that list of medications I’ve given you; I was pleased that part of this was having that impartially looked at and reviewed because I could imagine that there is a danger as these things gradually go on, over a period of years, so to know that there was a pharmacist, looking impartially at that, was something I was pleased about, and relieved about; it wasn’t a major worry I had before but when I thought about it, that’s very useful.’

(L002NI).

3.2 Personal factors

The overarching component ‘Personal factors’ on the 4FMA provided insight in terms of ‘personality & individual differences’ on the acceptability of the ACP intervention. Within that main theme, the sub-themes of ‘level of physical and mental ability’, ‘personal circumstances’, ‘care preferences’ and ‘financial aspects’ emerged as facilitators and barriers respectively.

3.2.1 Personality & individual differences

Personality factors seemed to impact on acceptability. Some participants were keen to present themselves as able and independent, yet their beliefs and behaviour associated with their health and future prospects varied. They reported keeping active and feeling well, taking a pro-active approach to maintaining their health, and believing that they could maintain their current level of health well into the future despite their comorbidities, and therefore were reluctant to accept that they needed an intervention at this point in time.

‘It’s difficult to know what’s in the future, you’d need a crystal ball, you know. I think at first I would try to keep as active as possible and would almost think like be very positive so, I think now ok, people can have strokes and heart attacks, but at the moment I don’t see that happening and I do try and keep reasonably healthy. I enjoy life, so.’

(L010NI).

Others appeared more resigned to their physical decline, perhaps less pro-active in promoting their own health, and focusing on the deficits of their situation. They welcomed the intervention with open arms.

‘Just if you could put in for a nurse coming, say, every three or four months to pop in and see how things are ‘cause over a few months things can change, especially at my age. On the 19th of this month, I am 82, so from then on you never know what’s round the corner.’

(F91087ROI).

3.2.2 Level of physical and mental ability

In addition to a variety of physical conditions, there was a wide range of mental agility observed in participants, ranging from very lucid and animated to hard to engage in meaningful exchange, and lack of focus. The latter was sometimes linked to e.g., hearing impairments and at other times seemingly an aspect of personality and individual circumstances. For some, impaired hearing exacerbated difficulties in communicating and relating, as did memory loss (F91087ROI). Participants who were aware of the complex and progressive nature of their conditions and understood that they would need help in the future to maintain their independence and quality of life, and potentially extend their life expectancy, readily acknowledged its benefits.

‘Well, it would be important to me if it kept me living and kept me moving, that’s the main thing that I would worry about if—as long as I knew that somebody was there to help.’

(L001NI).

Others, with readily available informal care, felt they were not currently disadvantaged by their condition/s, seemed unable or unwilling to identify with a frail cohort, and so did not regard ACP of immediate importance for them at that point in time.

‘I imagine that my physical condition is probably mild compared to some of the people that you have to deal with so I feel as though I am a bit of a fraud doing this because I don’t have real serious health problems that a lot of people do.’

(M008NI).

3.2.3 Personal circumstances

Having the opportunity to discuss fears and worries as part of the intervention was perceived as beneficial, particularly by those living alone and feeling isolated. Participants’ personal circumstances varied considerably and many were keen to share their stories, predominantly regarding personal loss, bereavement, regrets, family worries, relationship issues, and concerns over potential health deterioration. The intervention gave them the opportunity to do so while alleviating fears about an unknown future.

‘I feel more reassured about it now. I was frightened about the future but now I’ve discussed it and talked about it, I’m not as afraid of it now as I was.’

(L011NI).

3.2.4 Care preferences

When asked about their understanding about their future care needs, several participants expressed a strong aversion to the prospect of having to go into a care home, with some fearing financial loss or abuse.

‘The only thing I am fearful of is being put into a home and losing your money. I fear that. I say to [daughter] every now and again, I’m not going to no home, you know.’

(L003NI).

Confirming the appropriateness, convenience, and benefits of the ACP intervention, a clear preference for being cared for at home was expressed.

‘Say if you were confined to be—or all these kinds of things, you would rather have help in your home.’

(L005NI).

‘My mother and father both had to go into nursing homes, not nursing homes but residential homes, and I hope I never have to. Nobody knows.’

(M004NI).

3.3 Social support factors

The overarching component ‘social support factors’ on the 4FMA provided insight in terms of the influence of ‘loneliness & isolation’ on the acceptability of the ACP intervention. This main theme contains the sub-themes of ‘family carer’, ‘friends & family’, and ‘community support’.

Many participants reported good social support which appeared synonymous with greater life satisfaction and perceived better health, and therefore did not recognise the value of ACP to them at this point in time (e.g., L005NI, L007NI, L010NI, E38659ROI). Conversely, some felt ignored and uncared for and found the intervention very appropriate and beneficial.

‘Because as you get older and that, you just feel, you’re gonna be in the ground in another while, and who would bother or care about us, d’you know that sort of attitude that nowadays they…treat old people, as [partner] says about the doctor, it’s age, if your time’s up they forget about you then. Well, you’ve served society and its, you know, time to move on.’

(E54137ROI).

3.3.1 Loneliness and isolation

The intervention appeared to be particularly acceptable to patients who were lonely and isolated. This included but was not exclusive to those living in rural areas. Being divorced or widowed (n = 11, 32.3%), living alone (n = 13, 38.2%), very old age and a high level of frailty were all reasons for isolation and loneliness. Illness impacting on mobility and the inability to leave their house unaided stopped participants from engaging in activities they had previously enjoyed.

‘As I said before…how will I say it…my social life has gone. I have to stay in when I would love to go out and do different things, and I have to stay in because of my head.’

(F82139ROI).

Having impaired hearing was another contributing factor to social isolation making it very difficult to engage in conversations and meaningful social interaction. In all those instances, the nurses’ home visits were considered very convenient, and the intervention highly beneficial as participants felt listened to, reassured, cared for, and less isolated.

‘I found the whole thing very helpful because of, it makes you feel that you are not isolated or forgotten. That somebody is actually thinking, we’ll see if this person could get help, so I think it’s a sort of a reassurance, that’s what I felt.’

(L005NI).

3.3.2 Family carers & social support

The acceptability of the intervention was influenced by the level and quality of informal care, and social support currently received by participants. The better cared for someone felt, the less they thought the intervention was relevant to them, and vice versa. The majority of participants received informal care (n = 21, 61.8%), with nine being cared for by their spouse, 11 by adult children, and one by extended family, whom they were dependent on for daily tasks and for company. However, informal care was often difficult, with some family carers having additional caring commitments alongside being sole carer for their family member, e.g., adult children who had their own families and work obligations to consider (e.g., F73211ROI, E53448ROI) and struggled considerably with the added burden. Equally, some participants had caring obligations themselves. One, whose husband also took part in the study; and who cared for her son with mental health problems, found the information and actionable advice she received during the study highly beneficial to all of them.

‘I feel that, maybe getting the respite for [husband] was a start, and then [son] getting sorted, you know that he is much better, too, you know.’

(E59405ROI).

Despite often having health problems of their own, spousal family carers routinely provided some or all support (e.g., L004NI, L009NI, L002NI, L010NI, E69601ROI, E36988ROI, E39713ROI), leaving participants worrying what would happen if and when their spouse becomes unable to care for them due to illness.

‘While my wife’s living and we are together and, other than my back, we are both in fairly good health—I like to think we are—but that’s today, who knows next week?’

(LB010NI).

The intervention was regarded as particularly appropriate and beneficial by participants who lived alone, and devoid of a family carer experienced a lack of care, a sense of isolation, and uncertainty regarding care when their health deteriorates further.

‘I think for some people who are more isolated they feel that somebody has taken an interest and will follow it up with the doctor, I think psychologically it would be very important to have that, and very supportive, and ah, they know then that’s how it’s been, this has been made known.’

(L002NI).

Those with good support from family and friends saw somewhat less benefit in the ACP intervention. Participants derived a sense of safety, joy, and belonging from having extended family and good friends to support them (e.g., L007NI, L005NI, E39603ROI, E84283ROI, E34839ROI, F75177ROI, F82139ROI), adding to an overall sense of wellbeing and a reluctance to acknowledge the appropriateness of a forward planning health intervention.

‘I honestly don’t really see, looking into the future, whatever it may hold, I don’t think I’m going to really need any other support than what I’ve already got.’

(L007NI).

‘I’d be on the skype there to my son or my daughter and my brothers. It’s like being in the same room with them. If I want a bit of company, I go in next door and I give [name omitted] a shout and we might go off for a few pints.’

(F91087ROI).

3.3.3 Community support

Only a few participants responded to social prescribing during the intervention but where this was the case it was regarded as highly beneficial.

‘It was just going to a club and that was a great idea. It’s brilliant, its somewhere to go different you know and a bus collects us and all; it’s brilliant you know.’

(F44050ROI).

A number of participants reported having good neighbourly connections, and a supportive community, while others were isolated and lonely due to personal circumstances, including living alone, living rurally, and being of an introverted disposition. Some attended community groups e.g., Men’s Shed (E49587ROI), or were members of organizations, e.g., Parkinson’s Society (L002NI) which afforded them awareness and knowledge about where to turn for help if required. Having an existing social support network appeared to foster the belief that an ACP intervention was not immediately appropriate.

‘I think probably because we were reasonably well informed through the Parkinson Society, maybe the overall impact [of the intervention] for us would not be as marked as for someone who’s more isolated.’

(L002NI).

Group membership did not suit everyone, however, and not being able to drive or walk longer distances impacted on participants’ ability to uphold their social connections. The subsequent perception of being isolated contributed to a feeling of being ‘forgotten about’, leading to high acceptability of the intervention. Those who lived alone, with little help and few connections found the intervention very beneficial in terms of alleviating social isolation, providing reassurance that they are cared for, and that care is available to them.

‘What did you find was the most helpful part of taking part in the study?’ ‘Well you might laugh at me when I say this—the company. The company coming in. Yeah, that I wasn’t forgotten.’

(F82139ROI).

3.4 Healthcare provision factors

The overarching component ‘healthcare provision factors’ on the 4FMA provided insight in terms of the impact of participant ‘views on healthcare provision’ on the acceptability of the ACP intervention. The main theme contained the sub-theme of ‘relationship with GP’. Participants expressed satisfaction at their healthcare generally.

‘I can’t complain really about the health service. I know people do, but there’s nothing perfect; but as far as I am concerned … I can’t complain, for everything possible has been done for me.’

(L007NI).

3.4.1 Views on healthcare provision

Participants were aware of the high demand on GP surgeries and related primary care services, leading to excessive waiting times; and frequently reported not wanting to ‘bother’ the doctor. Participants whose conditions were relatively mild, with little need for frequent healthcare appointments, attributed less importance to the intervention than those with complex comorbidities who already needed frequent appointments. The latter readily perceived the benefits and convenience of a trained nurse coming to their home and assisting with current and future health needs. Some were aware of ongoing challenges within the health service and, in light of this, the appropriateness of the intervention.

‘The bottom line is that the doctors’ surgeries you know they are overrun anyway, if anything can be done to improve mobility, the movement of people in and out, that seems to be a jam, you could spend, sit 3.5 hours, and that’s the only part that I would like to see improved, you know and if this is a sort of an exercise that will go towards alleviating that you know, I’d be on for that.’

(E53448ROI).

Inequality in access to services due to rurality meant an even greater need for, and appreciation of, the benefits of the home based, nurse-led ACP intervention.

‘When you get to 70 you have to think about things, when you can’t drive, what are you gonna do, I mean I couldn’t really live in this area, because there is no buses, so that’s something that you have to consider, but if you get a bit of help from the health service that you can maintain your independence then that makes a big difference.’

(M008NI).

The benefits of having a trusted health professional visiting participants in their own home, providing holistic care with the view to safeguarding independence, were recognized and welcomed.

‘Well, I am hoping I’ll be able to keep as independent as I possibly can with advice and help, maybe from a nurse calling in occasionally just to check up on me and see if I’m alright.’

(L011NI).

3.4.2 Relationship with GP

GP involvement in the intervention was key as participants trusted their GP which facilitated recruitment and encouraged participation. In fact, some expected their GP to be involved as a matter of course.

‘I mean I would have been surprised if the GP hadn’t been involved because they are there in overall control of your health.’

(M008NI).

Despite trusting their GP participants reported avoiding making appointments where possible as they did not want to ‘bother’ them, potentially disappearing from the GP’s radar and not receiving the care they need. One participant provided insight into the reality of some people not wanting to ‘bother’ their doctor and how the intervention may benefit them.

‘I think it would be very useful for people to have this service in the future. I think it would be very useful if they could have a sort of person that would come along to people over a certain age and give them that reassurance. Talk to them about their health, talk to them about their mental feelings, and reassure them, and maybe advise them to go to their doctor and get more help. Some people when they get older they don’t want to bother anybody, they don’t want to go to the doctor, they don’t want to bother the doctor. But if you have somebody coming to you, who is a trained person who knows what they are doing and how to do it, it makes it so much easier.’

(L011NI).

Finally, no substantial differences in participant acceptability of the intervention were observed between the two jurisdictions, indicating trans-jurisdictional transferability and representativeness of the findings.

4. Discussion

4.1 Overview of findings

We sought to elicit user perceptions on the appropriateness, convenience, and benefits of the ACP intervention through qualitative interviews as per the ‘Adoption’ component of the ‘RE-AIM evaluative framework [31,35]. We found that patient acceptability of the ACP intervention was high, but depended on multiple factors. The newly established 4FMA has emerged from the findings and provides an evaluation framework for patient acceptability in terms of intervention and patient inherent facilitators and barriers. Four overarching components comprising intervention factors, personal factors, social support factors, and healthcare provision factors facilitated or hindered patient acceptability. In line with existing literature [15,16] what transpired is that multidisciplinary working [37] and a personalized approach [17,38] were key to the success of the ACP intervention. The intervention overall, its primary care setting with GP anchorage [5,38], home delivery by a specially trained nurse, and involvement of a pharmacist were considered both appropriate and beneficial. Some patients believed that the timing was not right for them, indicating perhaps a need for patient health education to ensure their understanding of the trajectory of their complex conditions and the value of ACP in light of this [39,40]. The home visits were regarded as convenient, and the medication review, psychosocial aspects of the nurses’ visits, and practical help provided were perceived as beneficial.

Notwithstanding the advantages of improved access to practical help and advice (e.g., dietary changes, exercise advice, guidance with making a will, a Do-Not-Resuscitate order, assistance with tax-free home adaptations, and social prescribing), and medication review, participants reported deriving great benefit from the psychosocial aspect of the nurses’ visits, their active listening, compassion, and personal validation. Psychosocial support concerns in older adults are often a feature of chronic physical health and social support issues [4146]. This was particularly true for those in our sample who felt lonely, isolated and ‘forgotten about, which notably included the hearing impaired [47].

Preventive home visits are potentially beneficial models of comprehensive care, reducing mortality and care-home admissions for frail, older adults [48]. Unanimously, participants valued the nurses’ home visits, as they felt comfortable and safe in their own environment. Importantly, experienced nurses in the project quickly built trust and established rapport, which enabled participants to speak openly about their physical, mental, and social difficulties. This was essential to both the holistic assessment and patient acceptability. Active listening, showing compassion, spending appropriate time with patients, helping to advise and make choices contributes to building a trusting respectful relationship [49]. Gaining patients’ trust is associated with acceptance of, and adherence to, recommendations, lower anxiety, accessing services, participant autonomy, and shared decision making [33].

GP involvement as facilitator and anchor for the intervention has proved crucial as participants unanimously held their GP in high esteem and trusted their judgement in terms of participation. Treatment acceptability has been suggested to refer to individual components of an intervention [34,35,37], with social acceptability denoting the appropriateness of the intervention considering individual differences [4345]. There was sometimes a reluctance to identify with a frail cohort in our sample. While some participants fully appreciated the intervention, others considered themselves to be still reasonably healthy and coping well, albeit with the support of their family carer. Therefore, they believed the ACP intervention was not immediately relevant to them. Perceived relevance depended on level of physical and mental ability, understanding of the intervention, individual differences–including personality, social support, personal, and financial circumstances—and insight into future trajectories of conditions. This brought into focus the importance of appropriate timing of the ACP intervention, personalisation, and patient health education. Health education for older adults can be very effective, both in terms of improving intervention adherence and potentially in reducing morbidity and excess mortality [40,50]. It could help improve health literacy [39,42] and ensure knowledge and understanding of ACP, thus facilitating timely uptake.

4.2 Implications

Based on the high acceptability of multidisciplinary working with GP anchorage, including a specially trained nurse and a pharmacist as the main stakeholders alongside the patients, there are some clear implications deriving from the findings of this feasibility cRCT. To render this primary care intervention feasible and acceptable it would require an allocated, specially trained ACP nurse and adjunct pharmacist, with direct access to other health and social care professionals. This would facilitate multidisciplinary working, improve access and patient outcomes. The approach should be patient–centred, with well-timed holistic assessment and treatment.

In terms of implications for future research, a full trial of the ACP intervention should take on board the feedback provided by participants in terms of acceptability. This means retaining those components which worked well (GP anchorage, home visits by a specially trained nurse, holistic assessment, medication review, person-centred approach, multidisciplinary working), while improving the timing of the intervention, and including health education in order to increase understanding of the intervention and to manage expectations. Health education for older adults can be very effective, both in terms of improving intervention adherence and potentially in reducing morbidity and excess mortality [40,50]. It could help improve health literacy [39,42] and ensure knowledge and understanding of ACP, thus facilitating timely uptake.

4.3 Strengths and limitations

The study’s strengths include provision of rich data on the participant acceptability of the ACP intervention, with zero attrition in the intervention group. Findings show an absence of cross-jurisdictional differences, indicating their transferability to other ethnically white populations. The data-driven (bottom-up) Four Factor Model of Acceptability (‘4FMA’) has been developed which could be applied to similar studies. While it shares some elements with Sekhon et al.’s [25] Theoretical Framework of Acceptability (‘TFA’), such as the TFA’s affective attitude and experience, which map onto the 4FMA’s intervention factors, it goes beyond that to include social support factors, healthcare provision factors, and personal factors. The model recognises these four factors, and their interaction as facilitators and barriers respectively for acceptability of the intervention. The study adds to research in participant acceptability of healthcare interventions.

As the sample was entirely ethnically white transferability to other ethnic groups may be limited. An unexpected limitation was that, despite an average PRISMA-7 score of 4.15, some participants perceived themselves ‘too well’ to fully benefit from the intervention indicating that initial assessment and selection criteria may warrant modification to ensure that timing of the intervention is appropriate for participants. The findings also underlined the importance of expectation management from the outset. Participants should receive health education as to the purpose and processes of ACP, and both should be clearly and continuously communicated to ensure participants know what they can expect and in which timeframe.

5. Conclusion

This primary care ACP intervention as a whole found unanimous acceptance in our sample, as did its individual components. The multidisciplinary approach through the collaboration of GP, nurse, and pharmacist provided the bedrock of the intervention. GP anchorage was key to successful recruitment and acceptability. Home visits by the trained nurse were enthusiastically received and perceived as very convenient and helpful, with socially isolated patients particularly welcoming the psychosocial aspect of the visits. The person-centred approach taken by the nurses was crucial to rapport building, holistic assessment, and acceptability. The medication review provided by the adjunct pharmacist was recognized as being a very useful aspect of the intervention. The timing of the intervention requires careful thought, and the inclusion of health education for patients is advisable. The newly developed 4FMA could be applied to similar patient acceptability studies. This ACP intervention has the potential to future-proof the management of complex, multiple conditions and improve quality of life for older adults, enabling them to live in their own home as independently as possible.

Supporting information

S1 File. Consolidated Criteria for Reporting Qualitative Studies (COREQ): 32-Item checklist.

(DOCX)

S2 File. The TIDieR (Template for Intervention Description and Replication) checklist.

(DOCX)

S3 File. Participants characteristics details.

(DOCX)

Acknowledgments

The authors wish to acknowledge the invaluable contribution of our participants, GPs and practice managers, and express our gratitude to them for giving so generously of their time. We thank the Northern Ireland Clinical Research Network [Primary Care] (NICRN PC) for the recruitment of GP practices and the delivery of the ACP intervention in Northern Ireland.

Data Availability

The data underlying this study cannot be shared publicly because they are qualitative patient interviews which contain personal and potentially identifiable information, and participants have consented to publication of anonymous quotes only. Requests for data can be made to Queen’s University Belfast Research Governance (contact via researchgovernance@qub.ac.uk) with appropriate ethical approval.

Funding Statement

The Anticipatory Care Planning Study is funded from INTERREG VA funding of (incl. 15% contribution from the Department of Health in Northern Ireland and Republic of Ireland) that had been awarded to the HSC Research & Development Division of the Public Health Agency Northern Ireland and to the Health Research Board in Ireland for the Cross-border Healthcare Intervention Trials in Ireland Network (CHITIN) project (Grant number: CHI-5426; recipient: Prof. Kevin Brazil; sponsor: Queen’s University Belfast: https://www.qub.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed in this paper do not necessarily reflect those of the European Commission or the Special EU Programmes Body (SEUPB).

References

  • 1.NHS England. Safe, compassionate care for frail older people using an integrated care pathway: Practical guidance for commissioners, providers and nursing, medical and allied health professional leaders. 2014. https://www.england.nhs.uk/wp-content/uploads/2014/02/safe-comp-care.pdf.
  • 2.NHS England. The NHS Long Term Plan. 2019. www.longtermplan.nhs.uk; https://www.longtermplan.nhs.uk/wp-content/uploads/2019/01/nhs-long-term-plan-june-2019.pdf.
  • 3.HSE, Clinical Strategy and Programmes Division. National Clinical Programme for Older People: Specialist Geriatric Team Guidance on Comprehensive Geriatric Assessment. 2016. https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/comprehensive-geriatric-assessment-document.
  • 4.CARDI, Centre for Ageing Research and Development in Ireland. Illustrating Ageing in Ireland North & South: Key Facts and Figures, compiled by McGill, P. 2010. ISSN: 2041-6997.
  • 5.Smith S, Soubhi H, Fortin M, Hudon C, O’Dowd T. Managing patients with multimorbidity: systemic review of interventions in primary care and community settings. British Medical Journal, 2012;345, e5202, 10.1136/bmj.e5202 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zulman DM, Asch SM, Martins SB, Kerr EA, Hoffman BB, Goldstein MK. Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness. Journal of General Internal Medicine, 2014;29: 3, 529–537. 10.1007/s11606-013-2616-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hayes B, Prihodova L, Walsh G, Doyle F, Doherty S. What’s up doc? A national population study of wellbeing of hospital doctors in Ireland. BMJ Open. 2017. 10.1136/bmjopen-2017-018023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Poghosyan L, Clarke SP, Finlayson M, Aiken LH. Nurse burnout and quality of care: cross-national investigation in six countries. Research in nursing & health, 2010;33: 4, 288–298. 10.1002/nur.20383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Department of Health. Transforming your care: A review of health and social care. Vision to action. A post consultation report; 2013. http://www.transformingyourcare.hscni.net/wp-content/uploads/2013/03/Transforming-Your-Care-Vision-to-Action-Post-Consultation-Report.pdf.
  • 10.Age UK. Age UK briefing–discharging older people from hospitals. 2016. https://www.ageuk.org.uk/globalassets/age-uk/documents/reports-and-publications/reports-and-briefings/care--support/age_uk_discharge_from_hospital_briefing_june_2016.pdf.
  • 11.Donnelly N, Humphries N, Hickey A, Doyle F. "We don’t have the infrastructure to support them at home": How health system inadequacies impact on long-term care admissions of people with dementia. Health Policy, 2017;121: 12, 1280–1287. 10.1016/j.healthpol.2017.09.020 [DOI] [PubMed] [Google Scholar]
  • 12.Coulter A, Roberts S, Dixon A. Delivering better services for people with long-term conditions: Building the House of Care. King’s Fund; 2013.
  • 13.Department of Health. Future health; a strategic framework for reform of the health service. 2012. https://www.gov.ie/en/publication/1dd5b7-future-health-a-strategic-framework-for-reform-of-the-health-service/.
  • 14.Health and Social Care Northern Ireland (HSC NI). Transforming your care: Strategic implementation plan. 2013. http://www.transformingyourcare.hscni.net/wp-content/uploads/2013/11/Transforming-Your-Care-Strategic-Implementation-Plan.pdf.
  • 15.Coulter A, Entwistle VA, Eccles A, Ryan S, Shepperd S, Perera R. Personalized care planning for adults with chronic or long-term health conditions. Cochrane Database of Systematic Reviews, 2015;3, CD10523, 10.1002/14651858.CD010523.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.The Health Foundation. Person-centred care made simple. 2016. https://www.health.org.uk/publications/person-centred-care-made-simple.
  • 17.NHS England and NHS Improvement. The framework for enhanced health in carehomes. 2020. www.england.nhs.uk/wp-content/uploads/2020/03/the-framework-for-enhanced-health-in-care-homes-v2-0.pdf.
  • 18.The Health Foundation. New analysis finds encouraging results in reducing emergency admissions from care homes. 2019. https://www.health.org.uk/press-release/new-analysis-finds-encouraging-results-in-reducing-emergency-admissions-from-care.
  • 19.Epstein RM, Street RL. The values and value of patient-centered care. The Annals of Family Medicine, 2011;9: 2, 100–103. 10.1370/afm.1215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pirhonen L, Gyllensten H, Hansson Olofsson E, Fors A, Ali L, Ekman I, Bolin K. The cost-effectiveness of person-centred care provided to patients with chronic heart failure and/or chronic obstructive pulmonary disease. Health Policy Open, 2020;1. 10.1016/j.hpopen.2020.100005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Scottish Government. Anticipatory care planning: Frequently asked questions. Health and Social Care, 2010. ISBN: 9780755992133. https://www.gov.scot/publications/anticipatory-care-planning-frequently-asked-questions/.
  • 22.Sekhon M, Cartwright M, Francis J. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Services Research, 2017;17: 88. 10.1186/s12913-017-2031-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Medical Research Council (Great Britain). Framework for design and evaluation of complex interventions to improve health: Health Services and Public Health Research Board, BMJ, 2000;321: 7262, 694–696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.British Geriatrics Society. Fit for Frailty–consensus best practice guidance for the care of older people living in community and outpatients settings–a report from the British Geriatrics Society. 2014; https://www.bgs.org.uk/resources/resource-series/fit-for-frailty.
  • 25.Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age and Aging, 2015;33, 148–152. 10.1093/ageing/afu157 [DOI] [PubMed] [Google Scholar]
  • 26.Lyndon H, Stevens G. Toolkit for General practice in supporting older people with frailty and achieving the requirements of unplanned admissions: Enhanced service. NHS; 2014.
  • 27.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 2007;19: 6, 349–357. 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 28.HoffmannT C, Glasziou P, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide BMJ 2014; 348: g1687. 10.1136/bmj.g1687 [DOI] [PubMed] [Google Scholar]
  • 29.Brazil K, Scott D, Wallace E, Clarke M, Fahey T, Gillespie P, et al. Anticipatory care planning intervention for older adults at risk of functional decline: study protocol for a primary care cluster feasibility randomized trial. Trials, 2020;21(168). 10.1186/s13063-020-4100-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Philip KE, Alizad V, Oates A, Donki DB, Pitsillides C, Syddal SP, et al. Development of an EASY-Care, for brief standardized assessment of the health and care need of older people; with latest information about cross-national acceptability. J Am Med Dir Assoc. 2014;15: 42–6. 10.1016/j.jamda.2013.09.007 [DOI] [PubMed] [Google Scholar]
  • 31.Gaglio G, Glasgow RE. The RE-AIM Framework: a systematic review of use over time. American Journal of Public Health. 2013;103: 6, e38–e46. 10.2105/AJPH.2013.301299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Miles M B, Huberman H A. Qualitative Data Analysis, 2nd ed. Sage Publications; 1994. [Google Scholar]
  • 33.Lyndon H, Stevens G. Toolkit for general practice in supporting older people with frailty and achieving the requirements of unplanned admissions: Enhanced service 2014. London: NHS; 2014. [Google Scholar]
  • 34.British Geriatrics Society, Turner G. Fit for frailty–consensus best practice guidance for the care of older people living in community and outpatient settings–a report from the British Geriatrics Society. London: British Geriatrics Society; 2014. [Google Scholar]
  • 35.Glasgow R E, Vogt T M, Boles S M. Evaluating the public health impact of health promotion interventions: The RE-AIM Framework. American Journal of Public Health, 1999;89, 1322–1327. 10.2105/ajph.89.9.1322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Staniszewska S, Brett J, Mockford C. The GRIPP checklist: Strengthening the quality of patient and public involvement reporting in research. International Journal of Technology Assessment in Health Care, 2011;27(4), 391–399. 10.1017/S0266462311000481 [DOI] [PubMed] [Google Scholar]
  • 37.Social Care Institute for Excellence (SCIE). Integrated Care Research and Practice. Multidisciplinary Teams: What are MDTs and why are the important to integration? 2018. https://www.scie.org.uk/integrated-care/research-practice/activities/multidisciplinary-teams.
  • 38.Wallace E, Smith SM, Fahey T, Roland M. Reducing emergency admissions through community based interventions. BMJ, 2016;352, h8617. 10.1136/bmj.h6817 [DOI] [PubMed] [Google Scholar]
  • 39.WHO. 7th Global Conference on Health Promotion, Track 2: Health literacy and health behavior. World Health Organisation. 2000. https://www.who.int/healthpromotion/conferences/7gchp/track2/en/.
  • 40.Mendonca FTNF, Santos AS, Buso ALZ, Malaquias BSS. Health education with older adults: action research with primary care professionals. Rev Bras Enferm [Internet]. 2017;70(4): 792–9. [Thematic Edition “Good Practices: Fundamentals of care in Gerontological Nursing”]. 10.1590/0034-7167-2016-0349 [DOI] [PubMed] [Google Scholar]
  • 41.Ross l, Jennings P, Williams B. Psychosocial support issues affecting older patients: A cross-sectional paramedic perspective. The Journal of Health Care Organization, Provision, and Financing, 2017; 54: 1–6. 10.1177/0046958017731963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet, 2012;380(9836): 37–43. 10.1016/S0140-6736(12)60240-2 [DOI] [PubMed] [Google Scholar]
  • 43.Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Pub Health. 2005;26: 469–500. 10.1146/annurev.publhealth.26.021304.144542 [DOI] [PubMed] [Google Scholar]
  • 44.Willis L, Goodwin J, Lee K-O, et al. Impact of psychosocial factors on health outcomes in the elderly. A prospective study. J Aging Health. 1997;9(3): 396–414. 10.1177/089826439700900307 [DOI] [PubMed] [Google Scholar]
  • 45.Bisschop MI, Kriegsman DM, Deeg DJ, Beekman AT, van Tilburg W. The longitudinal relation between chronic diseases and depression in older persons in the community: the Longitudinal Aging Study Amsterdam. J Clin Epidemiol. 2004;57(2): 187–194. 10.1016/j.jclinepi.2003.01.001 [DOI] [PubMed] [Google Scholar]
  • 46.Chen YM, Thompson EA. Understanding factors that influence success of home-and community-based services in keeping older adults in community settings. J Aging Health. 2010;22(3): 267–291. 10.1177/0898264309356593 [PubMed] [CrossRef] [Google Scholar]. [DOI] [PubMed] [Google Scholar]
  • 47.Pronk M, Deeg DJ, Smits C, et al. Hearing loss in older persons: does the rate of decline affect psychosocial health? J Aging Health. 2014;26(5): 703–723. 10.1177/0898264314529329 [DOI] [PubMed] [Google Scholar]
  • 48.Boult C, Green AF, Boult LB, Pacala JT, Snyder C, Leff B. Successful Models of Comprehensive Care for Older Adults with Chronic Conditions: Evidence for the Institute of Medicine’s ‘‘Retooling for an Aging America” Report [see editorial comments by Dr. David B. Reuben, pp. 2348–2349], J Am Geriatr Soc 2009;57: 2328–2337. 10.1111/j.1532-5415.2009.02571.x [DOI] [PubMed] [Google Scholar]
  • 49.Allinson M, Char B. How to build and maintain trust with patients. The Pharmaceutical Journal, 2016; 297: 7895, online URL: 20201862. [Google Scholar]
  • 50.Carter WB, McKenna M, Martin ML, Andresen EM. Health education: Special issues for older adults, Patient Education and Counseling, 1989;13(2), 117–131, 10.1016/0738-3991(89)90055-4 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Catherine J Evans

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

17 Nov 2020

PONE-D-20-30516

Acceptability of a nurse-led, person-centred, anticipatory care planning intervention for older people at risk of functional decline: A qualitative study

PLOS ONE

Dear Dr. Corry, 

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. 

Please respond to the editor and peer-review and comments detailed below.

==============================

Please submit your revised manuscript by 16th December 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Catherine J Evans, PhD, MSc, BSc (Hons)

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Additional Editor Comments:

Editor comments

Please to take care with formatting and proof reading and use of acronyms ROI and NI - please state respective country names in full for international readers to define acronyms when first used line 14 .....island of Ireland, Northern Ireland (NI) and the Republic of Ireland (ROI).

Please improve the clarity of the reporting in the methods

The methods state paper follows COREQ guidelines. Please include as a supplementary file your completed COREQ checklist for your paper and indicate in the manuscript (see supplementary file 1)

Please give detail on the intervention - the only detail given is the number of visits, that conducted by a research nurse who assessed health domains and liaised with GP and pharmacist to devise an anticipatory care plan. This is too brief for a complex intervention. Please review to the TIDier checklist for intervention description and replication. How was the research nurse trained, was the intervention manualized for consistency, did this incorporate any evidence-based interventions to e.g. medicine optimization i.e. STOPPfrail. If your population was older people with frailty, were the frailty syndromes considered in the assessment e.g continence, falls, reduced mobility. Or a general 'health assessment' - what informed the components. if this is detailed in the published trial protocol, please give sufficient detail of the intervention for the reader to understand what it comprised. How was this assessment 'person-centred' - this is the main message in the conclusion, yet no detail is given as to how this was person-cetnred. We need understanding on the detail in the intervention that person-centred and how e.g. asked what are the person's priorities, used an evidence-based tool e.g. person-centred comprehensive PCOM i.e. ESAS/IPOS, or Staying Well Check tool https://www.england.nhs.uk/wp-content/uploads/2017/11/dg-case-study-staying-well-check-tool.pdf

Did the same research nurse deliver the intervention and conduct the qualitative interviews? Please can you clarify in your methods. This is important for the rigour of your qualitative study. Please state in your methods when the qualitative interviews were undertaken in relation to the feasibility trial , e.g. after completion of the intervention at XX weeks post randomisation. Please also state if the interviews were conducted in a separate data collection time point or with the quant data. This is can be brief if detailed in the protocol. But this is important to understand the quality of your embedded qualitative study in the feasibility trial.

Please remove reporting on randomisation and sampling from the intervention detail. Randomisation and sampling could move to your sampling section.

In the methods 2.3 sample section - please move reporting on your sample to the results, and detail your method of sampling in the methods. The sampling states eligibility criteria for the trial. How were the participants for individual interviews purposively selected. Please state the criteria used.

Section 3 Findings

Please begin with the detail reporting the participants moving this detail from the methods section. Please provide more detail on your sample - mean/SD or median and IQR for PRISMA with interpretation e.g. moderate frailty; mean/median age and respective measures of dispersion, ethnicity; and illness factors e.g. main diagnosis group by ICD-10 chapter headings i.e. cardiovascular disease. or if multiple conditions state to give some sense of why considered this patient group likely to benefit from ACP . This data is important to understand your sample and applicability of your findings for other populations. I would suggest putting this demographic data in table 1: Participant characteristics. Also please detail how many interviews was a caregiver present. And please state how representative is your qualitative sample from the feasibility trial sample. How many people approached for the qualitative interview agreed to participate, what were the reasons for decline. Your qual work indicates that participants considered themselves 'too well' for the ACP, and those who were frailer indicated greater benefit. Please considered if the patients who agreed for interview were generally 'well' and more able to participate in this aspect of the study causing potential sampling bias.

Discussion

This is a qualitative study. Please use language describing your results aligned with qualitative methodology. For example line 496 - very effective, is quant positivist language. please use nouns/adjectives to report qual findings e.g. essential, crucial. Please review the discussion and structure to tighten the reporting on the main messages made. Key points seems the 'holistic' assessment undertaken by the research nurse and sense of being 'heard and valued', multidisciplinary team working particularly intervention of the pharmacist for medicine review/optimization. The role of the GP from your findings would seem more than 'appreciated' (line 580). Important to give a sense of how the intervention worked from the findings.

The RE-AIM framework is reported in the first para of the methods, but there is no further reference as to how RE_AIM was applied with the study e.g. used to inform design of the topic guide, data analysis, data interpreting? If RE-AIM not used in this aspect of the study please remove from the methods, or detail in your methods how applied and pick this up in the discussion. For example - How does RE_AIM relate to your 4FMA framework identified in your data analysis?

Conclusions - these need to be tightened to reflect your findings.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review this manuscript. It is a very interesting topic and good to see implementation acceptability being reported for ACP. Please find following my general, and more specific comments which I feel will make this a stronger manuscript.

Overall:

Background: You explain the background in great depth and there are some very relevant points. However, there are some statements which do not appear strictly relevant to building your argument. Reducing some of these peripheral statements would make this section stronger and improve readability.

Quotes: Throughout you change formatting between quotes indented and quotes within text. It is off-putting for the reader. Decide which and stick with it. Very short quotes (a few words) within the text are fine.

Discussion: This feels quite long and would benefit from greater contextualisation in the wider literature.

Implications: Again this feels long. The manuscript would benefit from the repetitions being cut and this section focussing on potential clinical and research impacts. You also mention health education here for the first time. Please introduce this in the Discussion and strengthen your argument with external literature. Overall you mention education five times, including in the conclusion, but this is not then mentioned in your abstract conclusions. If this is a significant implication it should be noted in the abstract.

Conclusions: This could be more clearly linked to your key messages.

Formatting: As PLOS ONE does not copyedit accepted manuscripts please do check over the full manuscript and figure for typographical errors such as use of semicolons and capitalisation etc.

Specific:

Line 10: I would have liked to see the main aim reflected here.

Lines 17-18: This is rather confusing. Is that four practices in the control and four intervention? Or four patients within each of the eight practices to control and four patients within each of the eight practices to intervention? Neither adds up to the n=34 you interviewed. I make 8 practices and 8 participants at each to be a total of 64, half of which, the intervention group, would be 32. Obviously you know how many people you interviewed so I must have misunderstood something in the way the numbers are explained. This needs clarifying throughout the manuscript.

Line 25-26: I do not understand the relevance of the hyphens here or later in the manuscript (e.g. Line 111)

Line 26-28: These are not articulated the same as the main headings in your findings section (Lines 161-163). Please correct.

Line 98: Can you add that participants gave informed consent here? I appreciate you say it below, but not to see it here raises a red flag to the reader.

Lines 105-106: See Lines 17-18 comment above.

Line 109: Move the bracketed element after 'for inclusion'. Also not sure you need the brackets, just a separate sentence. It would make this clearer that there is more data if the reader wishes.

Line 110: How many met the inclusion criteria? Why did you decide on only 8 from each practice? What is your rationale?

Line 112: What was the dose? Did some only receive one? Why didn't everyone receive the same dose? Specifying would help the reader decide the weight of the findings.

Line 115: Specify this was the nurse. 'They' can be confusing and imply it was the team of GP, pharmacist and nurse. If it was the team, this needs to be clarified throughout as previously it has implied it was the nurse that constructed the plan.

Line 121: Why face to face?

Line 131: Can you reference some of this literature?

Line 132: Did you use PPI? If not, it may be useful to explain your justification for this.

Line 144: When? Also January 2019?

Line 148: Who conducted the data analysis. All members of the research team? Is the research team the writing team?

Line 165: Make it clearer that this is a conceptual framework which you have developed and give more details. Also, potentially mention as an output in your abstract.

Line 172-176: Describing what is in the chart doesn't add anything. Try and give a high level summary for this theme here.

Line 194: Where is the evidence for this?

Line 226: Impossible is a very strong word. Challenging? Difficult?

Line 268-271: I find this statement very uncomfortable. How did you analyse negative and positive mindsets? I appreciate participants gave what appeared to be two different views. Maybe report on that rather than your interpretation of what mindset that meant they had.

Line 277: This is the first mention of frailty. Are you diagnosing frailty as a syndrome, if so, how, or saying some patients were more susceptible to functional decline? I would change this title or quantify. Perhaps Impact of (fluctuating?) mental and physical capacity?

Line 281: Personality. Can you explain further? Is this your analysis from the interview? If these are participants who are living with frailty, this could merely be a be a fluctuation rather than a person's personality.

Line 282: Was capacity one of your inclusion criteria? If not did that impact the intervention and your study? You do not mention this in your limitations or elsewhere.

Line 283-284: This sentence is confusing to me. (The following section makes perfect sense.) I am unsure what this togetherness of physical and mental capacity means, or where your evidence is to clarify it.

Line 324: The use of the word subsequent makes the sentence somewhat confusing.

Line 337 and 505: Again, please clarify what you mean by the term frailty in this context.

Line 357: Is spouse the right word when your example is regarding adult children?

Line 366-368: Can you evidence this with a quote?

Reviewer #2: I think this is a useful study to examine the effects of nurse-led Anticipatory care planning.

I did not understand the following points, so I would like to ask for additional explanation.

・In the Intervention part, it is stated that the GP was divided into the intervention group and the control group by Feasibility RCT, but if this study is a cluster RCT design, please describe the flow chart of the participants. If it's not a cluster RCT design, shouldn't this description be included in the sample?

In addition, although it is divided into an intervention group and a control group, please describe the correspondence to the control group.

・If this study is cluster RCT design, I think the sample size is small.

・Please specify the meaning and effect of collecting data separately for the intervention group and the control group.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 May 20;16(5):e0251978. doi: 10.1371/journal.pone.0251978.r002

Author response to Decision Letter 0


1 Feb 2021

Response to Reviewers

The authors would like to express their sincere gratitude to the editors and reviewers for giving of their valuable time to review our submission and providing their helpful suggestions for revision, all of which we have taken on board, and endeavoured to implement and incorporate, thus making it a stronger manuscript. We have addressed each point raised during the review and responded to it with the relevant remedial action and response as indicated below.

Points raised by Editors and Reviewers Authors’ response and action

Journal requirements:

1. Please ensure that your manuscript meets PLOS ONE’s style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

https://journals.plos.org/plosone/s/submission-guidelines

THE AUTHORS HAVE ENDEAVOURED TO ENSURE THAT THE MANUSCRIPT MEETS PLOS ONE’S STYLE REQUIREMENTS.

In your revised cover letter, please address the following prompts:

2. We note that you have indicated that data from this study are available upon request.

PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

OUR COVER LETTER WILL NOW INDICATE THAT WE HAVE SUBMITTED OUR ANONYMISED INTERVIEW DATA AS SUPPLEMENTARY FILES.

3. (Point 3 is a repeat of point 2.)

Additional Editor Comments:

Please to take care with formatting and proof reading and use of acronyms ROI and NI - please state respective country names in full for international readers to define acronyms when first used in line 14 … island of Ireland, northern Ireland (NI) and the Republic of Ireland (ROI). THE AUTHORS HAVE FOLLOWED THE PLOS FORMATTING GUIDELINES, AND HAVE CAREFULLY PROOF-READ THE MANUSCRIPT.

THE ABSTRACT NOW DISPLAYS COUNTRY NAMES IN FULL, FOLLOWED BY THEIR ACRONYMS AT FIRST MENTION IN LINES 21 AND 22:

THE FEASIBILITY CRCT INVOLVED EIGHT GENERAL PRACTITIONER (GP) PRACTICES AS CLUSTER SITES, STRATIFIED BY JURISDICTION, FOUR IN NORTHERN IRELAND (NI) (TWO INTERVENTION, TWO CONTROL), AND FOUR IN THE REPUBLIC OF IRELAND (ROI) (TWO INTERVENTION, TWO CONTROL). ‘ISLAND OF IRELAND’ DOES NOT USE AN ACRONYM.

Please improve the clarity of the reporting in the methods. THE AUTHORS HAVE ENDEAVOURED TO IMPROVE THE CLARITY OF THE REPORTING IN THE METHOD SECTION.

The methods state paper follows COREQ guidelines. Please include as a supplementary file your completed COREQ checklist for your paper and indicate in the manuscript (see supplementary file 1). THE COMPLETED COREQ CHECKLIST IS NOW INCLUDED AS A SUPPLEMENTARY FILE (S3) AND THIS IS INDICATED IN TEXT (PAGE 5).

Please give detail on the intervention - the only detail given is the number of visits, that conducted by a research nurse who assessed health domains and liaised with GP and pharmacist to devise an anticipatory care plan. This is too brief for a complex intervention. Please review to the TIDier checklist for intervention description and replication. MORE DETAIL HAS NOW BEEN PROVIDED ON THE INTERVENTION IN SECTION 2.2 IN THE METHODS, IN KEEPING WITH THE TIDieR Checklist, WHICH HAS BEEN COMPLETED AND IS ALSO PROVIDED AS A SUPPLEMENTARY FILE (S4), INDICATED ON PAGE 5.

How was the research nurse trained: RESEARCH NURSES COMPLETED A THREE-DAY TRAINING PROGRAMME DESIGNED TO ORIENT THEM TO THE INTERVENTION AND STUDY PROCEDURES. THE TRAINING WAS FACILITATED BY A CLINICIAN EXPERT IN THE FIELD. THIS IS NOW STATED ON PAGE 6.

Was the intervention manualized for consistency, did this incorporate any evidence-based interventions to e.g. medicine optimization i.e. STOPPfrail. If your population was older people with frailty, were the frailty syndromes considered in the assessment e.g., continence, falls, reduced mobility. Or a general 'health assessment' - what informed the components. if this is detailed in the published trial protocol, please give sufficient detail of the intervention for the reader to understand what it comprised. YES, THE INTERVENTION WAS MANUALISED WHICH IS REFLECTED IN THE TRAINING OF THE NURSES IN TERMS OF STANDARDISED ASSESSMENT, REPORTING, AND ENGAGEMENT WITH GP. THE MEDICATION REVIEW WAS BASED ON BEST EVIDENCE. THE ACP ASSESSMENT WAS CONDUCTED USING THE STANDARDISED EASY-CARE TOOL (Philip KE, Alizad V, Oates A, Donki DB, Pitsillides C, Syddal SP, et al. Development of an EASY-Care, for brief standardized assessment of the health and care need of older people; with latest information about cross-national acceptability. J Am Med Dir Assoc. 2014;15: 42-6) WHICH INVOLVES SEVERAL DOMAINS TO ENSURE A PERSONALISED HOLISTIC APPROACH. THIS WAS SUPPLEMENTED WITH A MEDICATION REVIEW. PAGE 6 NOW PROVIDES THIS INFORMATION.

How was this assessment 'person-centred' - this is the main message in the conclusion, yet no detail is given as to how this was person-centered. We need understanding on the detail in the intervention that person-centred and how e.g. asked what are the person's priorities, used an evidence-based tool e.g. person-centred comprehensive PCOM i.e. ESAS/IPOS, or Staying Well Check tool https://www.england.nhs.uk/wp-content/uploads/2017/11/dg-case-study-staying-well-check-tool.pdf

PAGES 5-6 NOW INCLUDE: THE RESEARCH NURSES (5) WERE TRAINED BY AN EXPERT CLINICIAN. TO ENSURE A PERSONALIZED CARE APPROACH, REGISTERED NURSES FROM BOTH JURISDICTIONS COMPLETED A THREE-DAY TRAINING PROGRAMME INCLUDING STUDY OVERVIEW, PRINCIPLES AND PRACTICE OF PERSONALIZED CARE, SHARED DECISION MAKING, CONDUCTION OF A HOLISTIC ASSESSMENT WITH THE EASY-CARE TOOL, AND COMPLETING A MEDICATION REVIEW IN COLLABORATION WITH A CLINICAL PHARMACIST.

How was intervention person-centred: THE STUDY AIMS, TRAINING PROVIDED TO THE RESEARCH NURSES, AND THE EASY-CARE ASSESSMENT TOOL ALL ALIGNED TO REFLECT PERSON-CENTRED CARE. THIS IS NOW BETTER EXPLAINED IN THE INTERVENTION SECTION, PAGES 5-7.

Did the same research nurse deliver the intervention and conduct the qualitative interviews? Please can you clarify in your methods. This is important for the rigour of your qualitative study. THIS HAS NOW BEEN CHANGED. PAGE 5 STATES THAT THE INTERVIEWS WERE CONDUCTED BY AN EXPERIENCED RESEARCHER. PAGES 5-6 STATE THAT THE INTERVENTION WAS CONDUCTED BY SPECIALLY TRAINED RESEARCH NURSES.

Please state in your methods when the qualitative interviews were undertaken in relation to the feasibility trial, e.g. after completion of the intervention at XX weeks post randomisation. Section 2.1 PAGE 5 STATES THAT THE QUALITATIVE INTERVIEWS WITH PARTICIPANTS TOOK PART AT 10-WEEK FOLLOW-UP (AUGUST TO OCTOBER 2019) IMMEDIATELY AFTER COMPLETION OF THE INTERVENTION AND AT THE SAME TIME AS TIME 2 QUANTITATIVE DATA COLLECTION.

Please also state if the interviews were conducted in a separate data collection time point or with the quant data. This is can be brief if detailed in the protocol. But this is important to understand the quality of your embedded qualitative study in the feasibility trial. WE HAVE NOW INDICATED THAT THE QUALITATIVE INTERVIEW TOOK PLACE AT THE SAME TIME AS TIME 2 QUANTATIVE DATA COLLECTION. SECTION 2.1 PAGE 5.

PLease remove reporting on randomisation and sampling from the intervention detail. Randomisation and sampling could move to your sampling section. THIS HAS BEEN MOVED TO THE SAMPLE SECTION.

In the methods 2.3 sample section - please move reporting on your sample to the results, and detail your method of sampling in the methods. THIS HAS BEEN DONE.

The sampling states eligibility criteria for the trial. How were the participants for individual interviews purposively selected. Please state the criteria used. ALL INTERVENTION PATIENTS WERE INTERVIEWED; WE HAVE NOW OMITTED THE WORD ‘PURPOSIVELY’. (PAGE 7).

Section 3 Findings

Please begin with the detail reporting the participants moving this detail from the methods section. THIS HAS BEEN DONE.

Please provide more detail on your sample - mean/SD or median and IQR for PRISMA with interpretation e.g. moderate frailty; mean/median age and respective measures of dispersion, ethnicity; and illness factors e.g. main diagnosis group by ICD-10 chapter headings i.e. cardiovascular disease. or if multiple conditions state to give some sense of why considered this patient group likely to benefit from ACP. This data is important to understand your sample and applicability of your findings for other populations. IN LINE WITH UK NATIONAL HEALTH SERVICE RECOMMENDATIONS THE BEST PRACTICE PRISMA-7 SCREENING TOOL WAS APPLIED TO IDENTIFY PATIENTS AT RISK OF FUNCTIONAL DECLINE / FRAILTY. PRISMA-7 IDENTIFIES THOSE WITH A SCORE OF THREE OR HIGHER AS AT INCREASED RISK FOR FRAILTY. THIS HAS NOW BEEN EXPLAINED IN THE ‘SAMPLE’ SECTION. MEANS AND SD FOR PRISMA SCORES AND FOR AGE HAVE NOW BEEN INCLUDED IN THE FINDINGS SECTION, AS HAVE GENDER AND ETHNICITY. AS PER INCLUSION CRITERIA ALL PARTICIPANTS HAD TWO OR MORE CHRONIC CONDITIONS.

THE SUITABILITY OF, AND RATIONALE FOR, THE CHOSEN PATIENT GROUP IS PROVIDED IN THE INTRODUCTION.

I would suggest putting this demographic data in Table 1: Participant characteristics. THIS TABLE (TABLE 1: PARTICIPANT CHARACTERISTICS) IS NOW INCLUDED (PAGE 7).

Also please detail how many interviews was a caregiver present. ONE CARE PARTNER ONLY WAS PRESENT AT INTERVIEW. THIS HAS NOW BEEN STATED IN THE FINDINGS.

And please state how representative is your qualitative sample from the feasibility trial sample. How many people approached for the qualitative interview agreed to participate, what were the reasons for decline. ALL INTERVENTION PARTICIPANTS WERE INVITED AND AGREED TO TAKE PART IN THE INTERVIEWS. THIS IS NOW STATED IN THE FINDINGS TOO.

Your qual work indicates that participants considered themselves 'too well' for the ACP, and those who were frailer indicated greater benefit. Please considered if the patients who agreed for interview were generally 'well' and more able to participate in this aspect of the study causing potential sampling bias. ALL INTERVENTION PARTICIPANTS (n=34) AGREED TO PARTICIPATE IN THE QUALITATIVE INTERVIEW THUS AVOIDING SAMPLING BIAS. THIS IS NOW STATED IN THE ‘SAMPLE’ SECTION.

Discussion

This is a qualitative study. Please use language describing your results aligned with qualitative methodology. For example line 496 - very effective, is quant positivist language. please use nouns/adjectives to report qual findings e.g. essential, crucial. WE HAVE ENDEAVOURED TO REMOVE SPECIFICALLY QUANTITATIVE LANGUAGE.

Please review the discussion and structure to tighten the reporting on the main messages made. Key points seems the 'holistic' assessment undertaken by the research nurse and sense of being 'heard and valued', multidisciplinary team working particularly intervention of the pharmacist for medicine review/optimization. The role of the GP from your findings would seem more than 'appreciated' (line 580). Important to give a sense of how the intervention worked from the findings. WE HAVE REVIEWED AND STRUCTURED THE DISCUSSION, FOCUSING ON THE MAIN POINTS FROM THE FINDINGS.

GP ANCHORAGE HAS INDEED BEEN IDENTIFIED AS ESSENTIAL RATHER THAN ‘APPRECIATED’. THIS HAS BEEN AMENDED ACCORDINGLY.

The RE-AIM framework is reported in the first para of the methods, but there is no further reference as to how RE_AIM was applied with the study e.g. used to inform design of the topic guide, data analysis, data interpreting? RE-AIM, MORE SPECIFICALLY THE ‘ADOPTION’ COMPONENT (WE HAVE CLARIFIED THAT NOW IN ‘DESIGN AND PROCEDURES’), WERE USED AS A FRAMEWORK TO GUIDE THE EVALUATION, AND AS SUCH GUIDED THE TOPIC GUIDE (AS STATED IN THE SECTION ‘INTERVIEW SCHEDULE’ OF THE METHODS), AND DATA ANALYSIS (STATED IN THE ‘DESIGN AND PROCEDURE’ SECTION OF THE METHODS).

If RE-AIM not used in this aspect of the study please remove from the methods, or detail in your methods how applied and pick this up in the discussion. For example - How does RE_AIM relate to your 4FMA framework identified in your data analysis? THIS HAS NOW BEEN EXPANDED UPON IN SECTION 2.4, AND TAKEN UP IN THE DISCUSSION.

Conclusions - these need to be tightened to reflect your findings. WE HAVE TIGHTENED THE CONCLUSIONS TO CLEARLY REFLECT OUR FINDINGS.

Reviewer #1:

Thank you for the opportunity to review this manuscript. It is a very interesting topic and good to see implementation acceptability being reported for ACP. Please find following my general, and more specific comments which I feel will make this a stronger manuscript. THE AUTHORS THANK REVIEWER #1 FOR TAKING THE TIME TO REVIEW THE MANUSCRIPT AND FOR THE VALUABLE INPUT AND RECOMMENDATIONS WHICH WE HAVE ENDEAVOURED TO FULLY INTEGRATE AND IMPLEMENT.

Overall:

Background: You explain the background in great depth and there are some very relevant points. However, there are some statements which do not appear strictly relevant to building your argument. Reducing some of these peripheral statements would make this section stronger and improve readability WE HAVE REMOVED STATEMENTS WHICH MAY BE CONSIDERED PERIPHERAL AND THUS NOT STRICTLY RELEVANT.

Quotes: Throughout you change formatting between quotes indented and quotes within text. It is off-putting for the reader. Decide which and stick with it. Very short quotes (a few words) within the text are fine. QUOTES ARE NOW FREESTANDING THROUGHOUT THE FINDINGS SECTION WITH THE EXCEPTION OF VERY SHORT QUOTES.

Discussion: This feels quite long and would benefit from greater contextualization in the wider literature. WE HAVE TIGHTENED AND CONTEXTUALISED THE DISCUSSION.

Implications: Again this feels long. The manuscript would benefit from the repetitions being cut and this section focusing on potential clinical and research impacts. You also mention health education here for the first time. Please introduce this in the Discussion and strengthen your argument with external literature. Overall you mention education five times, including in the conclusion, but this is not then mentioned in your abstract conclusions. If this is a significant implication it should be noted in the abstract. WE HAVE REMOVED REPETITIONS AND FOCUSED ON POTENTIAL CLINICAL AND RESEARCH IMPACTS.

WE HAVE INTRODUCED HEALTH EDUCATION IN THE DISCUSSION AND BROUGHT IN WIDER LITERATURE. PATIENT EDUCATION HAS ALSO NOW BEEN INCLUDED IN THE ABSTRACT.

Conclusions: This could be more clearly linked to your key messages. WE HAVE LINKED THE CONCLUSION MORE CLEARLY TO THE KEY MESSAGES.

Formatting: As PLOS ONE does not copyedit accepted manuscripts please do check over the full manuscript and figure for typographical errors such as use of semicolons and capitalisation etc. WE HAVE ENDEAVOURED TO IDENTIFY AND REMOVE ALL TYPOGRAPHICAL ERRORS.

Specific:

Line 10: I would have liked to see the main aim reflected here. THE MAIN AIM OF THIS PAPER IS TO REPORT ON PATIENT ACCEPTABILITY OF THE PRIMAY CARE BASED ACP INTERVENTION. THIS IS NOW MORE CLEARLY REFLECTED HERE.

Lines 17-18: This is rather confusing. Is that four practices in the control and four intervention? Or four patients within each of the eight practices to control and four patients within each of the eight practices to intervention? Neither adds up to the n=34 you interviewed. I make 8 practices and 8 participants at each to be a total of 64, half of which, the intervention group, would be 32. Obviously you know how many people you interviewed so I must have misunderstood something in the way the numbers are explained. This needs clarifying throughout the manuscript. WE HAVE NOW CLARIFIED NUMBERS OF PRACTICES AND PARTICIPANTS BOTH IN THE ABSTRACT AND IN THE METHODS SECTION.

Line 25-26: I do not understand the relevance of the hyphens here or later in the manuscript (e.g. Line 111) THE HYPHENS HAVE BEEN REMOVED.

Line 26-28: These are not articulated the same as the main headings in your findings section (Lines 161-163). Please correct. THIS HAS NOW BEEN CORRECTED.

Line 98: Can you add that participants gave informed consent here? I appreciate you say it below, but not to see it here raises a red flag to the reader. THIS HAS BEEN ADDED.

Lines 105-106: See Lines 17-18 comment above. IN LINE WITH THE REQUIREMENTS OF THIS REVIEW THIS INFORMATION HAS NOW BEEN MOVED TO THE ‘SAMPLE’ SECTION, HOWEVER, IT HAS BEEN AMENDED IN ORDER TO CLARIFY NUMBERS, AND TO BRING IT IN LINE WITH THE AMENDED ABSTRACT.

Line 109: Move the bracketed element after 'for inclusion'. Also not sure you need the brackets, just a separate sentence. It would make this clearer that there is more data if the reader wishes. THE BRACKETS HAVE BEEN REPLACED BY A SEPARATE SENTENCE.

Line 110: How many met the inclusion criteria? Why did you decide on only 8 from each practice? What is your rationale? 73 PATIENTS MET THE INCLUSION CRITERIA. DETAILS ON RATIONALE REGARDING SAMPLING HAVE NOW BEEN PROVIDED.

Line 112: What was the dose? Did some only receive one? Why didn't everyone receive the same dose? Specifying would help the reader decide the weight of the findings. THIS DETAIL IS NOW INCLUDED IN SECTION 2.2: THE INTERVENTION, IN THE METHOD SECTION. NUMBER OF HOME VISITS DEPENDED ON COMPLEXITY OF NEEDS.

Line 115: Specify this was the nurse. 'They' can be confusing and imply it was the team of GP, pharmacist and nurse. If it was the team, this needs to be clarified throughout as previously it has implied it was the nurse that constructed the plan. ‘THEY’ HAS NOW BEEN REPLACED WITH ‘THE NURSES’ HERE.

Line 121: Why face to face? THIS WAS AN ERROR AND SHOULD HAVE READ “… WERE SELECTED TO TAKE PART IN A FACE-TO-FACE INTERVIEW.” WE HAVE NOW REMOVED THE EXPRESSION ALTOGETHER.

Line 131: Can you reference some of this literature? WE HAVE NOW RECTIFIED THE OMISSION AND INCLUDED REFERENCES FOR THE RE-AIM FRAMEWORK.

Line 132: Did you use PPI? If not, it may be useful to explain your justification for this. YES, PPI WAS USED. THIS HAS NOW BEEN INCLUDED HERE.

Line 144: When? Also January 2019? YES, POST ETHICAL APPROVAL AND PRIOR TO INDIVIDUAL BASELINE DATA COLLECTION. BASELINE WAS STAGGERED OVER SEVERAL MONTHS BETWEEN FEBRUARY AND JUNE 2019.

Line 148: Who conducted the data analysis. All members of the research team? Is the research team the writing team? THE FIRST AUTHOR IN COLLABORATION WITH ANOTHER MEMBER OF THE RESEARCH TEAM (PAGE 11). THE INTERVENTION NURSES ARE NOT PART OF THE WRITING TEAM.

Line 165: Make it clearer that this is a conceptual framework which you have developed and give more details. Also, potentially mention as an output in your abstract. WE HAVE NOW CLARIFIED THAT THIS IS A NEW CONCEPTUAL FRAMEWORK WHICH WE HAVE DEVELOPED AND PROVIDED A LITTLE MORE DETAIL. WE HAVE ALSO INCLUDED THE FRAMEWORK IN THE ABSTRACT.

Line 172-176: Describing what is in the chart doesn't add anything. Try and give a high level summary for this theme here. WE HAVE EDITED THIS PARAGRAPH TO REFLECT THE SUGGESTED CHANGES.

Line 194: Where is the evidence for this? EVIDENCED THROUGH PARTICIPANT FEEDBACK DURING INTERVIEWS, AND ILLUSTRATED THROUGH THE QUOTES THROUGHOUT THE FINDINGS SECTION. THIS HAS NOW BEEN STATED IN TEXT.

Line 226: Impossible is a very strong word. Challenging? Difficult? THIS HAS BEEN CHANGED TO ‘CHALLENGING’.

Line 268-271: I find this statement very uncomfortable. How did you analyse negative and positive mindsets? I appreciate participants gave what appeared to be two different views. Maybe report on that rather than your interpretation of what mindset that meant they had. THIS SECTION HAS NOW BEEN RE-WRITTEN IN LINE WITH THE REVIEWER’S SUGGESTION.

Line 277: This is the first mention of frailty. Are you diagnosing frailty as a syndrome, if so, how, or saying some patients were more susceptible to functional decline? I would change this title or quantify. Perhaps Impact of (fluctuating?) mental and physical capacity? WE HAVE CHANGED THE TITLE OF THIS SECTION AS PER YOUR SUGGESTION.

Line 282: Was capacity one of your inclusion criteria? If not did that impact the intervention and your study? You do not mention this in your limitations or elsewhere. CAPACITY WAS NOT AN INCLUSION CRITERION PER SE BUT THE ABILITY TO COMPLETE AN ENGLISH LANGUAGE POSTAL QUESTIONNAIRE. THIS IS NOW INCLUDED IN THE SAMPLE SECTION.

Line 283-284: This sentence is confusing to me. (The following section makes perfect sense.) I am unsure what this togetherness of physical and mental capacity means, or where your evidence is to clarify it. WE HAVE REMOVED THIS SENTENCE.

Line 324: The use of the word subsequent makes the sentence somewhat confusing. WE HAVE REMOVED THE WORD ‘SUBSEQUENTLY’.

Line 337 and 505: Again, please clarify what you mean by the term frailty in this context. THE WORD FRAIL HAS BEEN REPLACED WITH ‘INFORM’ IN THESE SENTENCES [WHAT WAS MEANT WITH ‘FRAIL COHORT’ WAS THAT PARTICIPANTS IN THIS STUDY HAD A PRISMA-7 FRAILTY SCORE OF 3+.]

Line 357: Is spouse the right word when your example is regarding adult children? ‘SPOUSE’ WAS NOW REPLACED WITH ‘FAMILY MEMBER’.

Line 366-368: Can you evidence this with a quote? A SUPPORTING QUOTE HAS NOW BEEN INCLUDED HERE.

Reviewer #2: I think this is a useful study to examine the effects of nurse-led Anticipatory care planning.

I did not understand the following points, so I would like to ask for additional explanation. THE AUTHORS THANK REVIEWER #2 FOR TAKING THE TIME TO REVIEW THE MANUSCRIPT AND FOR THE VALUABLE INPUT AND RECOMMENDATIONS WHICH WE HAVE ENDEAVOURED TO FULLY INTEGRATE AND IMPLEMENT. WE HAVE RESPONDED TO THE REQUEST FOR ADDITIONAL EXPLANATIONS BELOW.

In the Intervention part, it is stated that the GP was divided into the intervention group and the control group by Feasibility RCT, but if this study is a cluster RCT design, please describe the flow chart of the participants. If it's not a cluster RCT design, shouldn't this description be included in the sample? PARTICIPANT RECRUITMENT HAS NOW BEEN DETAILED IN THE SAMPLE SECTION.

In addition, although it is divided into an intervention group and a control group, please describe the correspondence to the control group. WE HAVE NOW INCLUDED THIS DETAIL IN THE SAMPLE SECTION: PARTICIPANTS WERE CONTACTED BY A MEMBER OF THE RESEARCH TEAM TO INFORM THEM OF THEIR ALLOCATION TO THE CONTROL VERSUS THE INTERVENTION GROUP AFTER CONSENT HAD BEEN OBTAINED AND BASELINE STANDARDISED INTERVIEW COMPLETED.

If this study is cluster RCT design, I think the sample size is small. THIS IS THE RECOMMENDED SAMPLE SIZE FOR FEASIBILITY PURPOSES AND IS DETAILED IN OUR PROTOCOL.

Please specify the meaning and effect of collecting data separately for the intervention group and the control group. THIS PAPER REPORTS ON THE PATIENT ACCEPTABILITY OF THE ACP INTERVENTION. TO ELICIT THIS, INTERVENTION PARTICIPANTS WERE INTERVIEWED REGARDING THEIR VIEWS AND PERCEPTIONS OF THE INTERVENTION. NO SUCH QUALITATIVE DATA WERE COLLECTED FROM THE CONTROL GROUP WHO DID NOT RECEIVE THE INTERVENTION.

QUANTITATIVE DATA WAS COLLECTED SIMULTANEOUSLY FROM INTERVENTION AND CONTROL PARTICIPANTS, HOWEVER, THIS WILL BE THE TOPIC OF ANOTHER PAPER.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

N/A

WE HAVE UPLOADED FIG 1 TO PACE AND APPENDED THE RESULTING DOCUMENT WITH OUR RESUBMISSION.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Catherine J Evans

10 Mar 2021

PONE-D-20-30516R1

Acceptability of a nurse-led, person-centred, anticipatory care planning intervention for older people at risk of functional decline: a qualitative study

PLOS ONE

Dear Dr. Corry, 

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

Thank you for your careful consideration and response to the initial peer review comments. We have reviewed your response and detailed minor revisions required for your manuscript to meet publication standard required for PLOS ONE. Please review and respond to the editor and peer review comments below. 

=====================

Please submit your revised manuscript by 7th April 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Catherine J Evans, PhD, MSc, BSc (Hons)

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Please use language of frail rather than infirm throughout. (see #Reviewer 1 point below)

Methods

Detail on the RCT needs to be in the design and procedure section including reference for the published protocol. This then details the design at the beginning of the methods for the reader to understand the intervention and qualitative interviews are part of a trial.

Reporting follows COREQ guidance. This needs to be detailed in the design section as relates to the whole study reporting, not only the intervention. Can you move up from the intervention detail and report in the design subsection.

Sample

Can you revise this for clarity – moving information on the trial design to the study design section.

State clearly at the beginning sample eligibility, then give the detail. Such as ..

The qualitative interviews included all participants allocated to the intervention group in the feasibility cluster RCT. Detailing on the sampling method for the trial can remain in this sub-section.

Table 1 – can you include this detailed table as a supplementary file, and cite in the manuscript as supplementary. It is important information, but is not main results. Include  in the results  table 1 reporting characteristics of the qual sample (see below).

Line 156 – please remove pre-COVID, not needed as implicit from the dates given that data collection occurred before the 2020 pandemic

Interview schedule - line 164 - please state how PPI supported the study and give an example to illustrate contribution to the interview schedule. Please detail if a PPI group - number, how worked with them referring to GRIPP reporting for PPI.

Findings

Can you present in the results a table 1 summary table of the qualitive interview participant characteristics e.g. Age median (range IQR), gender – proportions, average PRISMA score i.e.d median and spread, jurisdiction – proportions, allocated group etc. You can then reduce the narrative reporting on the participant results to main points and refer to the table 1.

Line 210 – please remove detail on methods of data analysis. This is repeating detail given in the methods. Please report your findings to indicated what found – past tense. Not we sought to elicit – future tense as you are reporting findings. Reporting on the themes and framework begin as a new para, Line 209 new para to report the themes identified. State suggestion below, then give the detail re the themes and the framework

Our findings on the acceptability of the intervention formed five main themes:

Use of the word correct – review 1, suggested use appropriate timing. I agree with this – from your findings this is about the appropriate time for the person. Not a correct time or un-correct time which implies a biomedical perspective of disease stage. This is about the priorities for the person, not their disease stage.

Discussion

Limitations – line 611 – no cross jurisdictional differences, but the sample all identified as ethnically White. Transferability is limited to ethnically White. Please indicate in the limitations this point sample ethnically White. This limits transferability to Black and Minority ethnic groups.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review the amended manuscript. It is, I feel, far clearer and stronger. I do have some additional comments which I believe will strengthen the manuscript further:

Throughout - I assume comments from the author team have been answered to everyone's satisfaction? e.g. lines 709 & 713 on the annotated copy.

Throughout - Changing frail to infirm and changing the heading. This is perhaps a misunderstanding of my comment. I was concerned you had categorized frailty without explaining what that meant to you within the paper. You have now explained PRISMA-7 and its role in flagging frailty well and so may I ask that you go back to using the term frail, or older people living with frailty, or frail elders. Infirm has its own negative connotations.

Throughout - Appropriate rather than 'correct' timing.

Line 103 - The reader needs to know a bit more contextualisation. "at the same time as collecting time 2 quant data" isn't enough.

Lines 160 - 174 - level of detail is much better, but perhaps the actual questions could sit in a separate table/box so the reader doesn't get lost now you've added the aim of the questions. Also, may need to explain why you are using advance CP and anticipatory CP here.

Line 163-164 - could you mention briefly how the PPI supported this?

Line 187 - much clearer. Can you add the initials of the writing team member here?

Line 589 - 590 - Could you expand a little on patient education and appropriate timing, and link this to the wider literature?

Reviewer #2: Thank you for revise your paper. I think it's a very useful paper. Because you had revision it carefully, I was able to understand. I am waiting for a research paper with other data to be published.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 May 20;16(5):e0251978. doi: 10.1371/journal.pone.0251978.r004

Author response to Decision Letter 1


24 Mar 2021

Response to Reviewers 19/03/2021

Once again, the authors would like to express their sincere gratitude to the editors and reviewers for giving of their valuable time to review our resubmission and providing further helpful suggestions for revision, all of which we have endeavoured to take on board, implement and incorporate, thus making it a stronger manuscript. We have addressed each point raised during the second review and responded to it with the relevant remedial action and reply as indicated in the table below.

Points raised by Editors and Reviewers Authors’ response and action

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

WE HAVE REVIEWED THE REFERENCES FOR COMPLETION AND CORRECTNESS.

WE HAVE ADDED TWO MORE REFERENCES (36 AND 50) AND ADJUSTED NUMBERING THROUGHOUT.

Additional Editor Comments (if provided):

THE AUTHORS THANK THE EDITOR FOR REVIEWING THE AMENDED MANUSCRIPT AND SUGGESTIONS TO FURTHER STRENGTHEN IT. WE HAVE ENDEAVOURED TO RESPOND TO EACH POINT AS BELOW.

Please use language of frail rather than infirm throughout. (see #Reviewer 1 point below) ‘INFIRM’ WAS REPLACED WITH ‘FRAIL’ THROUGHOUT (2 REPLACEMENTS MADE).

Methods

Detail on the RCT needs to be in the design and procedure section including reference for the published protocol. This then details the design at the beginning of the methods for the reader to understand the intervention and qualitative interviews are part of a trial.

DETAILS ABOUT THE INTERVENTION, INCLUDING REFERENCE TO THE PUBLISHED PROTOCOL HAVE NOW BEEN MOVED TO THE BEGINNING OF THE ‘DESIGN AND PROCEDURE’ SECTION IN THE METHODS. THE PARAGRAPH ABOUT THE QUALITATIVE INTERVIEWS IMMEDIATELY FOLLOWS THIS.

Reporting follows COREQ guidance. This needs to be detailed in the design section as relates to the whole study reporting, not only the intervention. Can you move up from the intervention detail and report in the design subsection.

THE SENTENCE: ‘THIS PAPER REPORTS ON PATIENT ACCEPTABILITY OF THE INTERVENTION, AND FOLLOWS THE COREQ GUIDELINES FOR REPORTING QUALITATIVE RESEARCH [27] (SEE S3) AND THE TIDIER CHECKLIST [28] (SEE S4)’ HAS NOW BEEN MOVED TO SECTION 2.1 ‘DESIGN AND PROCEDURE’.

Sample

Can you revise this for clarity – moving information on the trial design to the study design section.

State clearly at the beginning sample eligibility, then give the detail. Such as .. THE SENTENCE PERTAINING TO TRIAL DESIGN HAS BEEN MOVED TO THE STUDY DESIGN SECTION. THE SENTENCE DENOTING INCLUSION CRITERIA HAS BEEN MOVED TO LEAD ON FROM DESCRIPTION OF ELIGIBLITY AND INCLUSION (LINES 136-139).

The qualitative interviews included all participants allocated to the intervention group in the feasibility cluster RCT. Detailing on the sampling method for the trial can remain in this sub-section. THIS INFORMATION REMAINED IN THIS SUB-SECTION.

Table 1 – can you include this detailed table as a supplementary file, and cite in the manuscript as supplementary. It is important information, but is not main results. Include in the results table 1 reporting characteristics of the qual sample (see below).

THIS TABLE IS NOW INCLUDED AS SUPPLEMENTARY FILE 5 (S5): TABLE 2. PARTICIPANT CHARACTERISTICS, AND IS REFERRED TO AS SUCH IN THE MANUSCRIPT.

Line 156 – please remove pre-COVID, not needed as implicit from the dates given that data collection occurred before the 2020 pandemic

THE PHRASE ‘PRE-COVID’ HAS BEEN REMOVED HERE.

Interview schedule - line 164 - please state how PPI supported the study and give an example to illustrate contribution to the interview schedule. Please detail if a PPI group - number, how worked with them referring to GRIPP reporting for PPI. THE FOLLOWING SENTENCES HAVE NOW BEEN INSERTED HERE:

FOLLOWING GRIPP GUIDELINES ON PPI REPORTING [36] WE ENGAGED THREE PPI (ONE IN ROI, TWO IN NI) IN AN ADVISORY CAPACITY TO ATTEND REGULAR PROJECT TEAM MEETINGS AND TO DISCUSS PROTOCOL, ANALYSIS, AND DISSEMINATION, AS WELL AS PROGRESSION AND NEXT STEPS, SPECIFICALLY TO CONSULT ON STUDY DOCUMENTS, INCLUDING QUALITATIVE AND QUANTITATIVE INTERVIEW SCHEDULES, TO ENSURE INCORPORATION OF THE VITAL LAY PERSON PERSPECTIVE. AN EXAMPLE OF PPI INPUT TO THE QUALITATIVE INTERVIEW SCHEDULE IS THE CHANGE FROM ‘DID YOU FEEL ACTIVELY INVOLVED IN YOUR DISCUSSIONS WITH THE NURSE TO IDENTIFY YOUR HEALTHCARE NEEDS?’ TO ‘DID YOU HAVE ENOUGH INPUT IN IDENTIFYING YOUR HEALTH NEEDS AND DEVELOPING YOUR CARE PLAN?’

Findings

Can you present in the results a table 1 summary table of the qualitive interview participant characteristics e.g. Age median (range IQR), gender – proportions, average PRISMA score i.e.d median and spread, jurisdiction – proportions, allocated group etc. You can then reduce the narrative reporting on the participant results to main points and refer to the table 1. PREVIOUS TABLE 1 WITH DETAILED PARTICIPANT DETAILS HAS NOW BEEN INCLUDED AS A SUPPLEMENTARY FILE TABLE 2 (S5) AS REQUESTED ABOVE. WE HAVE NOW INCLUDED A SUMMARY TABLE WITHIN THE TEXT (TABLE 1), SHOWING AGE MEAN AND SD, GENDER, PRISMA SCORE MEAN AND SD, AND DISTRIBUTIONS OF ROI/NI, INTERVENTION/ CONTROL, AND URBAN/ RURAL.

Line 210 – please remove detail on methods of data analysis. This is repeating detail given in the methods. Please report your findings to indicated what found – past tense. Not we sought to elicit – future tense as you are reporting findings.

Reporting on the themes and framework begin as a new para, Line 209 new para to report the themes identified. State suggestion below, then give the detail re the themes and the framework

Our findings on the acceptability of the intervention formed five main themes:

Use of the word correct – review 1, suggested use appropriate timing. I agree with this – from your findings this is about the appropriate time for the person. Not a correct time or un-correct time which implies a biomedical perspective of disease stage. This is about the priorities for the person, not their disease stage. DETAIL ON METHODS OF ANALYSIS HAVE BEEN REMOVED.

WE HAVE INSERTED A PARAGRAPH AT LINE 222 AND STARTED SENTENCE IN PAST TENSE (‘ANALYSIS OF INTERVIEW DATA RESULTED IN FIVE MAIN THEMES …’), OMITTING THE PREVIOUS ‘WE SOUGHT TO ELICIT’.

THE WORD ‘CORRECT’ HAS BEEN REPLACED BY ‘APPROPRIATE’ IN RELATION TO TIMING THROUGHOUT.

Discussion

Limitations – line 611 – no cross jurisdictional differences, but the sample all identified as ethnically White. Transferability is limited to ethnically White. Please indicate in the limitations this point sample ethnically White. This limits transferability to Black and Minority ethnic groups. IN LIMITATIONS, LINE 638 NOW READS: ‘AS THE SAMPLE WAS ENTIRELY ETHNICALLY WHITE TRANSFERABILITY TO OTHER ETHNIC GROUPS MAY BE LIMITED.’

Reviewer #1:

Thank you for the opportunity to review the amended manuscript. It is, I feel, far clearer and stronger. I do have some additional comments which I believe will strengthen the manuscript further: THE AUTHORS THANK REVIEWER #1 FOR REVIEWING THE AMENDED MANUSCRIPT AND SUGGESTIONS TO FURTHER STRENGTHEN IT. WE HAVE ENDEAVOURED TO RESPOND TO EACH POINT AS BELOW.

Throughout - I assume comments from the author team have been answered to everyone's satisfaction? e.g. lines 709 & 713 on the annotated copy.

APOLOGIES; IT IS UNCLEAR WHAT THIS POINT IS REFERRING TO? LINES 709 AND 713 OF THE MANUSCRIPT ARE IN THE REFERENCE SECTION. WE ARE HAPPY TO ADDRESS THIS ONCE CLARIFIED.

Throughout - Changing frail to infirm and changing the heading. This is perhaps a misunderstanding of my comment. I was concerned you had categorized frailty without explaining what that meant to you within the paper. You have now explained PRISMA-7 and its role in flagging frailty well and so may I ask that you go back to using the term frail, or older people living with frailty, or frail elders. Infirm has its own negative connotations. WE HAVE CHANGED THE TERM ‘INFIRM’ BACK TO ‘FRAIL’ THROUGHOUT THE MANUSCRIPT.

THE HEADING HAS NOT CONTAINED EITHER OF THESE TERMS BUT REFLECTS THE WORDING OF THE STUDY TITLE WITH THE TERM ‘AT RISK OF FUNCTIONAL DECLINE’ WHICH IS USED THROUGHOUT THE MANUSCRIPT AS WELL.

Throughout - Appropriate rather than 'correct' timing. THIS HAS BEEN AMENDED THROUGHOUT THE MANUSCRIPT (2 INCIDENTS).

Line 103 - The reader needs to know a bit more contextualisation. "at the same time as collecting time 2 quant data" isn't enough. THIS SENTENCE (STARTING AT LINE 121) READS NOW: THIS INVOLVED QUALITATIVE INTERVIEWS WITH PARTICIPANTS IN THEIR OWN HOMES AT 10-WEEK FOLLOW-UP (AUGUST TO OCTOBER 2019) FOLLOWING COMPLETION OF THE INTERVENTION, DURING THE SAME VISIT AT WHICH TIME 2 QUANTITATIVE DATA WERE COLLECTED. PARTICIPANTS COMPLETED THE QUANTITATIVE QUESTIONNAIRE WITH THE RESEARCHER AND WERE THEN INTERVIEWED.

Lines 160 - 174 - level of detail is much better, but perhaps the actual questions could sit in a separate table/box so the reader doesn't get lost now you've added the aim of the questions. Also, may need to explain why you are using advance CP and anticipatory CP here. THE QUESTIONS HAVE NOW BEEN PLACED IN A BOX WITHIN THE TEXT.

WE HAVE REPLACED THE MENTION OF ‘ADVANCE CARE PLANNING’ WITH ‘ANTICIPATORY CARE PLANNING’.

Line 163-164 - could you mention briefly how the PPI supported this?

THE FOLLOWING SENTENCE HAS NOW BEEN INSERTED HERE (STARTING AT LINE 166):

FOLLOWING GRIPP GUIDELINES ON PPI REPORTING [36] WE ENGAGED THREE PPI IN AN ADVISORY CAPACITY TO ATTEND REGULAR PROJECT TEAM MEETINGS AND TO DISCUSS PROGRESSION, NEXT STEPS, AND CONSULT ON STUDY DOCUMENTS, INCLUDING QUALITATIVE AND QUANTITATIVE INTERVIEW SCHEDULES, TO ENSURE INCORPORATION OF THE VITAL LAY PERSON PERSPECTIVE. AN EXAMPLE OF PPI INPUT TO THE QUALITATIVE INTERVIEW SCHEDULE IS THE CHANGE FROM ‘DID YOU FEEL ACTIVELY INVOLVED IN YOUR DISCUSSIONS WITH THE NURSE TO IDENTIFY YOUR HEALTHCARE NEEDS?’ TO ‘DID YOU HAVE ENOUGH INPUT IN IDENTIFYING YOUR HEALTH NEEDS AND DEVELOPING YOUR CARE PLAN?’

Line 187 - much clearer. Can you add the initials of the writing team member here? THE INITIALS OF THE TEAM MEMBER – KB – HAVE NOW BEEN INSERTED HERE.

Line 589 - 590 - Could you expand a little on patient education and appropriate timing, and link this to the wider literature? LINES 601-604 NOW READ: HEALTH EDUCATION FOR OLDER ADULTS CAN BE VERY EFFECTIVE, BOTH IN TERMS OF IMPROVING INTERVENTION ADHERENCE AND POTENTIALLY IN REDUCING MORBIDITY AND EXCESS MORTALITY [40,50]. IT COULD HELP IMPROVE HEALTH LITERACY [39,42] AND ENSURE KNOWLEDGE AND UNDERSTANDING OF ACP, THUS FACILITATING TIMELY UPTAKE.

Reviewer #2:

Thank you for revise your paper. I think it's a very useful paper. Because you had revision it carefully, I was able to understand. I am waiting for a research paper with other data to be published. THE AUTHORS THANK REVIEWER #2 FOR THEIR REVIEW AND COMMENDATION.

WE CURRENTLY HAVE ANOTHER QUALITATIVE PAPER UNDER REVIEW, AND ONE IN PREPARATION. WE ARE ALSO PREPARING A PAPER REPORTING ON ALL QUANTITATIVE ASPECTS OF THE STUDY, INCLUDING A HEALTH ECONOMIC EVALUATION.

AUTHORS’ CHANGE

ACKNOWLEDGEMENTS WE HAVE ALTERED THE SENTENCE RECOGNISING THE NICRN CONTRIBUTION TO BE A MORE SPECIFIC ACKNOWLEDGEMENT WHICH NOW READS:

‘WE THANK THE NORTHERN IRELAND CLINICAL RESEARCH NETWORK [PRIMARY CARE] (NICRN PC) FOR THE RECRUITMENT OF GP PRACTICES AND THE DELIVERY OF THE ACP INTERVENTION IN NORTHERN IRELAND.’

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Catherine J Evans

7 Apr 2021

PONE-D-20-30516R2

Acceptability of a nurse-led, person-centred, anticipatory care planning intervention for older people at risk of functional decline: a qualitative study

PLOS ONE

Dear Dr. Corry, 

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Please see my detailed comments below. Key points are to revise table 1, move table 2 to supplementary and remove supplementary files reporting the full transcripts. Please reads detailed comments below and respond in full. 

=============================

Please submit your revised manuscript by 3rd May 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Catherine J Evans, PhD, MSc, BSc (Hons)

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Thank you for carefully reviewing the peer review and editor comments, and amending the manuscript accordingly. Most comments have been responded to. However, as editor I have comments below. Please respond to these in full.

Key words

Please review to ensure using MeSH terms to describe the study – the population, focus, methods. Examples of potential MeSH terms:

Frailty; Primary health care; Qualitative Research; Randomised Controlled Trial

Line 123 – please reviewing phrasing to improve clarity

During the visit, quantitative data was also collected. Participants completed the quantitative questionnaires for timepoint two, then the qualitative interview.

Line 126 – can you state the interview length range and the measure of average – presume median average of 60 minutes (range x to y)

Line 128 – is the experienced female researcher one of the co-authors? If yes, please insert the initials

Line 128 - Hospital admission is this any admission, or unplanned only? If any admission leave as is, if unplanned only please state unplanned hospital admission

Table 1 – this is reporting the results. Table 1 reporting the participants should be in the results section. Please can you report the characteristics of the sample in line with your stated inclusion criteria. Detail a row for each inclusion criteria with the measure clearly stated such as, Mean (SD), if n state n= . The reader needs to be able to assess the extent your sample reflects the sampling criteria, and understand the characteristics of the participants. Please look at publications in PLOS One and reporting style for participant characteristics, typically reported in a table. You report in the results characteristics of the participants by the respective jurisdiction. If this distinction is important, report this in table 1 using a column for each jurisdiction to report the respective characteristic. Or if not important, report as a single sample.

You want to use table 1 to convey the important characteristics of your sample relevant to your findings and conclusions drawn. Lines 212-222 –this data should be reported in your table 1 e.g. living status, marital status. In the narrative reporting of the results, report main points important to emphasize, such factors increasing risk of functional decline like frailty, average age, number of conditions, polypharmacy, number of unplanned hospital admissions in the past year. Only one partner present – is an important point. Add to the table detail re identified family carer – and who they were. This is information is reported in section 3.3.2. Reporting in the table would improve clarity and give emphasis, particularly as care partners is a main theme and essential for readers to understand extent the participants identified an family carer or not to appraise critically findings on the importance of family carers. Care partners – this is an unusual way to describe family carers or informal carers. Can you state family carers (including close friends) and use term carers or caregivers throughout . In figure 1, state family carers – this would improve clarity as to who is being referred too.

Table 1 should state Average number of medications as medication review a component of the intervention and a theme identified re acceptability. Important for the reader to understand extent of polypharmacy and relevance of medication

review

Table 2 is the raw data – this needs to be moved to supplementary. 

Lines 150-161 is long giving detail on the trial. Please reduce and keeping reporting on methods relevant to the paper reporting the qualitative interview studies. Please state Out of 73 patients meeting eligibility, 64 were recruited and allocated to intervention (n=32) or control (n=32) group after consent and baseline data collection. All patients in the intervention group were invited to complete a qualitative interview at 10-week follow-up…... Detail on variation in recruitment by GP practice does not seem relevant to reporting in this paper about the qualitative interview findings. Detail on consent is reported in the ethical considerations.

Line 179 – topic guides, items included the following. Please either list or put in a figure, and indicate in the text end of line 178 (see figure 1)

Line 185 – move up to line 174 to keep reporting on the interview guide together. State all interviews were conducted between August to October 2019. Please remove sentence re unaffected by coronavirus pandemic. The sentence has no relevance to the study.

Supplementary files – all the transcripts are made available. This seems ethically inappropriate as I am assuming the participants consented for publication of quotes, not the whole transcript with potential for them to be identified by e.g. their GP, family members. Please remove the transcripts as supplementary and indicate data is available with appropriate ethical approvals from the authors. You can deposit the raw data in a national repository for qualitative data. This then ensures the research governance and management to the data, such as destroyed after stated time as indicated in your ethical approval.

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 May 20;16(5):e0251978. doi: 10.1371/journal.pone.0251978.r006

Author response to Decision Letter 2


5 May 2021

Response to Reviewers 16 April, 2021

The authors would like to express their sincere gratitude to the Editor for giving of her valuable time to review our resubmission and providing further helpful suggestions for revision, all of which we have endeavoured to take on board, implement and incorporate, thus making it a stronger manuscript. We have addressed each point raised during the last review and responded to it with the relevant remedial action and reply as indicated in the table below.

Points raised by Editors and Reviewers Authors’ response and action

Key words

Please review to ensure using MeSH terms to describe the study – the population, focus, methods. Examples of potential MeSH terms:

Frailty; Primary health care; Qualitative Research; Randomised Controlled Trial

We have now used MeSH on Demand (nih.gov) in conjunction with the Editor’s suggestions for Keywords. They are now:

Keywords: older adults, frailty, anticipatory care planning, primary health care, qualitative research, randomised controlled trial, UK, Republic of Ireland

Line 123 – please review phrasing to improve clarity. During the visit, quantitative data was also collected. Participants completed the quantitative questionnaires for timepoint two, then the qualitative interview. Lines 122-123 now read: ‘During the visit quantitative data was also collected. Participants completed the quantitative questionnaires for the 10-week follow-up, then the qualitative interview.’

Line 126 – can you state the interview length range and the measure of average – presume median average of 60 minutes (range x to y)

Line 125 now states the correct length and median average for the qualitative interview: ‘The qualitative interviews had a median average length of nine minutes (range: three to 24 minutes)’ …

The Authors thank the Editor for highlighting this point as the 60 minutes previously stated were inclusive of the quantitative data collection.

Line 128 – is the experienced female researcher one of the co-authors? If yes, please insert the initials

Line 127 - Yes, she is, and her initials have now been inserted in the sentence: ‘The interviews were conducted by an experienced female researcher (DC) who had not met the participants prior to interview.’

Line 128 - Hospital admission is this any admission, or unplanned only? If any admission leave as is, if unplanned only please state unplanned hospital admission

Line 136 – ‘hospital admission’ refers to any admission; sentence was left as is.

Table 1 – this is reporting the results. Table 1 reporting the participants should be in the results section.

Please can you report the characteristics of the sample in line with your stated inclusion criteria. Detail a row for each inclusion criteria with the measure clearly stated such as, Mean (SD), if n state n= . The reader needs to be able to assess the extent your sample reflects the sampling criteria, and understand the characteristics of the participants.

Please look at publications in PLOS One and reporting style for participant characteristics, typically reported in a table.

You report in the results characteristics of the participants by the respective jurisdiction. If this distinction is important, report this in table 1 using a column for each jurisdiction to report the respective characteristic. Or if not important, report as a single sample.

Table 1 has been moved to the results section.

The characteristics of the sample have been reported in line with our stated inclusion criteria (a row for each*), with the addition of gender, marital status & living arrangements; and urbanicity, and family carer participation. Means (SD) and n have been provided where applicable.

We have inspected a number of publications in PLOS ONE and reporting style (table) for participant characteristics and have applied it to Table 1.

The distinction is unimportant in the context of this paper, and the sample was homogenous across jurisdictions, therefore characteristics are reported as a single sample.

* While patient health conditions

were recorded in the nurses’ clinical record, this information was not considered relevant to the study objectives thus not abstracted and analysed for research purposes.

You want to use table 1 to convey the important characteristics of your sample relevant to your findings and conclusions drawn. Lines 212-222 –this data should be reported in your table 1 e.g. living status, marital status.

In the narrative reporting of the results, report main points important to emphasize, such factors increasing risk of functional decline like frailty, average age, number of conditions, polypharmacy, number of unplanned hospital admissions in the past year.

Only one partner present – is an important point. Add to the table detail re identified family carer – and who they were.

This is information is reported in section 3.3.2. Reporting in the table would improve clarity and give emphasis, particularly as care partners is a main theme and essential for readers to understand extent the participants identified a family carer or not to appraise critically findings on the importance of family carers.

Care partners – this is an unusual way to describe family carers or informal carers. Can you state family carers (including close friends) and use term carers or caregivers throughout.

In figure 1, state family carers – this would improve clarity as to who is being referred too.

Living arrangements and marital status have now been included in Table 1.

The narrative has now been edited according to the Editor’s suggestions as below (We do not have detail on planned vs unplanned hospital admissions. While patient health conditions

were recorded in the nurses’ clinical record, this information was not considered relevant to the study objectives thus not abstracted and analysed for research purposes.):

‘The average PRISMA-7 score of 4.15 (1.12) in our sample was indicative of an increased risk of frailty and the need for further clinical review. As per inclusion criteria all participants had 2 or more chronic conditions; were taking on average 11.39 medications; had 5.2 GP visits during the past year; and an average of 6.4 inpatient nights in the previous year. Only one family carer actively took part in the interview.

All participants were white European. Gender was evenly distributed, with a mean sample age of 80.13. The majority were married (61.8%) and lived in urban areas (58.82%).’

This family carer was present in the sense that she actively participated in the interview, unlike the other family carers who were present in the house or in the room but did not contribute to the interview. We have included this information in Table 1 now.

The term ‘care partners’ has now been replaced with ‘family carers’ throughout the manuscript and in Figure 1. We have put Figure 1 through PACE again following this change.

Table 1 should state Average number of medications as medication review a component of the intervention and a theme identified re acceptability. Important for the reader to understand extent of polypharmacy and relevance of medication

review

We have now included the average number of medications in Table 1.

Table 2 is the raw data – this needs to be moved to supplementary.

Table 2 has been removed from the manuscript and will be submitted as supplementary file S3.

Lines 150-161 is long giving detail on the trial. Please reduce and keeping reporting on methods relevant to the paper reporting the qualitative interview studies.

Please state Out of 73 patients meeting eligibility, 64 were recruited and allocated to intervention (n=32) or control (n=32) group after consent and baseline data collection. All patients in the intervention group were invited to complete a qualitative interview at 10-week follow-up…...

Detail on variation in recruitment by GP practice does not seem relevant to reporting in this paper about the qualitative interview findings. Detail on consent is reported in the ethical considerations. Lines 145-149 now read: ‘Out of 73 patients meeting eligibility, 65 were recruited and randomly allocated to intervention (n=34) or control (n=31) group after consent and baseline data collection. All patients in the intervention group were invited to complete a qualitative interview at 10-week follow-up (August to October, 2019) to explore the acceptability of the ACP intervention.’

All other details in this paragraph in terms of recruitment, allocation, and consent have been removed.

Line 179 – topic guides, items included the following. Please either list or put in a figure, and indicate in the text end of line 178 (see figure 1)

Line 167 now reads … Topic guide items included the following:

The items are now listed.

Line 185 – move up to line 174 to keep reporting on the interview guide together.

State all interviews were conducted between August to October 2019.

Please remove sentence re unaffected by coronavirus pandemic. The sentence has no relevance to the study.

This sentence has now been moved up and starts at line 164.

We now state that all interviews were conducted between August and October 2019.

We have removed the sentence regarding the coronavirus pandemic.

Supplementary files – all the transcripts are made available.

This seems ethically inappropriate as I am assuming the participants consented for publication of quotes, not the whole transcript with potential for them to be identified by e.g. their GP, family members.

Please remove the transcripts as supplementary and indicate data is available with appropriate ethical approvals from the authors. You can deposit the raw data in a national repository for qualitative data. This then ensures the research governance and management to the data, such as destroyed after stated time as indicated in your ethical approval. We have removed the transcripts. (They had been added following request at first review.)

We are in agreement with the Editor.

We have removed the supplementary files and indicated that data is available with appropriate ethical approvals from the authors.

Decision Letter 3

Catherine J Evans

7 May 2021

Acceptability of a nurse-led, person-centred, anticipatory care planning intervention for older people at risk of functional decline: a qualitative study

PONE-D-20-30516R3

Dear Dr. Corry, 

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Catherine J Evans, PhD, MSc, BSc (Hons)

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Catherine J Evans

11 May 2021

PONE-D-20-30516R3

Acceptability of a nurse-led, person-centred, anticipatory care planning intervention for older people at risk of functional decline: a qualitative study

Dear Dr. Corry:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Catherine J Evans

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Consolidated Criteria for Reporting Qualitative Studies (COREQ): 32-Item checklist.

    (DOCX)

    S2 File. The TIDieR (Template for Intervention Description and Replication) checklist.

    (DOCX)

    S3 File. Participants characteristics details.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The data underlying this study cannot be shared publicly because they are qualitative patient interviews which contain personal and potentially identifiable information, and participants have consented to publication of anonymous quotes only. Requests for data can be made to Queen’s University Belfast Research Governance (contact via researchgovernance@qub.ac.uk) with appropriate ethical approval.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES